ZD-06519
KY1702
HY-0012
Tc99m-MAA
CA103
MP-1959
NB002
Dendranibs
MB-104(MustBio)
AT-I9 (Ucello Therapeutics)
RD127
EOC237
TQB-2103
ATG-034
PH009-1
ITGB6 ProTriTAC
VIP-280
ABO2011
Human papillomavirus 9-valent vaccine, recombinant(Merck & Co.)
MDNA19-MDNA213 fusion protein
BPT567
PTT-4256
JBI-589
AVA-NP
MDNA213-PE
HCB101
BGI-9004
KIN-7136
VIP-550
BTX-9341
SPR1-0117
Cetuximab biosimilar(Guilin Sanjin)
Anti-PDL1 monoclonal antibody(Keymed Biosciences)
Gefurulimab
Anti-PDL1 monoclonal antibody/TGFBR2 Fusion protein(Keymed Biosciences)
Bevacizumab biosimilar(Shanghai Henlius)
Recombinant humanized monoclonal antibody MIL95(Beijing Mabworks)
Trotabresib
AT–01
VLS-1488
BL-M11D1
Anti-CD73 monoclonal antibody(Keymed Biosciences)
Darovasertib
BI-0252
PH020-803
MYX2449
TROP2 ProTriTAC
VIP-1339
HMPL-415S1
SDT-101
Recombinant anti-CTLA-4 human monoclonal antibody(Shanghai Henlius)
FTX-001(Flamingo Therapeutics)
TTX-RIGA
WD-940
Recombinant oncolytic herpes simplex virus type 1(Shanghai Yunying Medical Technology)
NK510
HGN-002
HGP-2142
HGT-04
HGT-05
HGT-01
HGT-03
HGN-001
HGT-02
Dendritic Cells(Radboud University Medical Center)
GB-X01
CAM-9782
Pear-016
GF-CART01
TMER1-i
RCT-001
PZ-8603-111
VacV-001
ARD-102
GSI-01
CT-102
SY-1558
NCT-01
YN-014
ZY-0002
Misetionamide
MT-125
MB-201(Menluo Biotech)
SYS6010
SCR-9171
LTZ-121
SY-5933
ONC-2
JRT-39
SP-002
SCR-9168
SCR-8572
NK-011
ND-004 (NewDEL Biotech)
SCR-9140
KSX-01
OI-101
XYD-9668-198
MAI-009
SS-008871
ORN101
18F-FAPI
FPI-2107
DAT-6000
FPI-2068
DAT-2000
PH 804 enhanced T cell therapy
Dendritic Cell Vaccine(H. Lee Moffitt Cancer Center and Research Institute)
CCT-361814
DAT-5000
PH 804 enhanced NK Cell therapy
DAT-1000
DAT-3000
PH-894 enhanced T cell therapy
DAT-4000
PH 762 enhanced TIL therapy
FZ-AD004
TSN-222
Cetuximab biosimilar (EnZene Biosciences)
HSB-3215
Personalised tumour trained lymphocytes therapy(NEOGAP Therapeutics)
QLH12002
PSCA(dCH2)BBzeta-CAR T-cells(City of Hope Medical Center)
Autologous Tumour Vaccine(Vaxine)
Peginterferon alfa-2b(Merck & Co)
Padeliporfin
Donor Derived HIV-Specific T-cells (DD HST-NEETs)(Children's National Research Institute)
AIT-101
AZD-5335
HSK-38008
CS-1003(Chipscreen Biosciences)
Autochimeric antigen receptor T cell(Beijing DCTY® Biotech)
CD-17001
CS-1007
CSXY-0002
CSXY-0004
CSXY-0003
CT-0525
LCB-42A
INTERFERON ALFA-2B(Merck Sharp & Dohme )
CD-70001
CSXY-0001
CD-80001
AMG-305
CO-1
IMYX-5
Sodium pentaborate pentahydrate
GS-9911
mRNA plus Lysate-loaded Dendritic Cell Vaccine(M.D. Anderson Cancer Center)
RO-7656594
TFF2-MSA
Anti-CD19 and anti-CD20 bicistronic CAR T- cells(National Cancer Institute)
JNJ-3790339
IACS-6274
DGK Inhibitor(BMS)
BAY-2862789
Prizloncabtagene autoleucel
ISM-4312A
PM534
重组抗PD-L1和TGF-β双功能融合蛋白（华兰基因）
重组人源化PDL1/CTLA-4双特异性单域抗体Fc融合蛋白（康宁杰瑞）
重组人源化抗HER2双特异性抗体（康宁杰瑞）
贝伐珠单抗生物类似药 (mAbxience)
重组人源化抗Claudin 18.2单克隆抗体(恺兴生命科技)
重组人源化抗PCSK9单抗 (上海君实)
异槲皮素
那屈肝素钙
ETS-003
盐酸多柔比星/透明质酸钠
AM-9747
LB217
BSA01
ACT-1002-4391
RGT-018
HPK1抑制剂(AZ)
ADGN-121
FR-027
靶向Nectin-4/CD3双特异抗体(BioAtla)
SS008871
钇[90Y]-NM600
Cbl-b抑制剂(先声药业)
ENT-H1
H11E11-2V1
CD19/CD20双靶向CAR-T(美天旎)
H182
ABM-3249
HPB-092
CD19靶向CAR-iNKT(Arovella)
UCI-1001
M3i
FAPPEP-SLNP
AVA3996
HK054-V
ABN202
PR-619
NCT-547
mIL-12v Fc
BG34-200
KS18
SSFF-02
HL2401
BCMA/GPRC5D双靶向CAR-NK(先博生物)
eIF4E(PIC Therapeutics)
PM058
UR241-2
ISM6466A
HSN608
ADGN-123
AL2
Degrader 9069
KSHN001126
IRX4647
TiOxNPs
ABBV-MALT1
PIN-A1
IPGA05
KL-50
IDO1/TDO2抑制剂(Idorsia Pharma)
ADGN-531
UNC7713
AO-252
SU056
EC914
PPA24
TREX-1 inhibitor(Tempest)
CL-AD-100
ON05+Lu177-di-HSG
ENPP1抑制剂(LegoChem Biosciences)
PDS-0330
靶向PD-1/IL-7双抗(OSE)
TGN-1062
SQ2270
DL78
YIV-818-A
GENA-104A16
HZ-Q1070
SHASTA01
VBI‑003
TEB-17231
SMIP34
RMC-4627
CJRB-101
PM1024
NB-115
K-11706
KA-1874
TAG72靶向CAR T(City of Hope)
Vrtx153
TATX-200
SCR9168
S1004-11
SW-682
FCN-683
C-10386
MBS314
AVA-NP-695
DX-002
TS-002266
HND-01
ICX-101
NB-55
DLL3/CD3/CD137三特异性抗体(中外制药)
PARP1抑制剂(Duke Street Bio)
TRX-221
CL-AR-200
DTriTE
PARP7抑制剂(Duke Street Bio)
PRMT5抑制剂(Ryvu Therapeutics)
SHP2抑制剂(kanaph Therapeutics)
A2AR抑制剂(Aurigene)
RNF31抑制剂(IQS)
CIDD-97
靶向LILRB1/LILRB2双抗(OncoResponse)
RM-046
Cyclin A/B抑制剂(Circle)
靶向APP抗体(Genome & Company)
obi-R007
KA-1769
NSP-1047
ST317
SPX5551
AZD0754
DP-9024
靶向IL-22单克隆抗体(BioAtla)
PSMAxCA9 ICT
TI2-N17
BI-732
GrB-Fc-SD1
HX011
LAG3Pep
CD19靶向CAR-NK(Charles River)
DP-9149
MX69-114b
LGR5靶向CAR-T(Adelaide)
UCT-001024
D02
β-catenin肽抑制剂(FogPharma)
dpADC
Compound 1(Accent Therapeutics)
Microtubule抑制剂(BERG)
SCR-8388
HZ-R078
FIS103
RG6353
WBMP-4
锕[225Ac]-NM600
ALD2510
AP-3-84
SYX3759
DA-4505
JW-1-283
GPX4抑制剂(Sonata Therapeutics)
TNRX-257
mKBscFv-CPP
BDB101
TP-6379
ISM3412
BT115386
JRT39
PoxSTG
NB-73
NR-V04
BpAb-2
αCD20-IgG1-huEndoP125A
MA242
LNF1901
靶向CEACAM1抗体(逻晟生物)
LCB97
UCT-000445
靶向HER2/CD3抗体(BioAtla)
VBI-002
CET019
INTASYL 27790
YD23
GPC1靶向VHH纳米抗体CAR-T(NIH)
C-09066
靶向Siglec-6/CD3双抗(OSU)
NMS-0963
全人源化抗Her2抗体(A&G Pharmaceutical)
STARD5抑制剂(Virginia Commonwealth University)
抗CEACAM5抗体偶联物(赛诺菲)
RM-042
OKI-1546
CWHM-974
REGN10597
GPX4抑制剂(Arpeggio)
PODO447
ADGN-122
DCZ0415
AR RIPTAC(Halda Therapeutics)
CTLA-4/STAT3靶向适配体-siRNA嵌合体
TGFβR2敲除iPSC衍生NK细胞(Cellectis)
TY-0584
PD-L1靶向CAR-T(VaxCell)
DW91170
FOLR1靶向CAR-T(美天旎)
HVEM18-10
C-14207
CD44v6靶向CAR-T(Go Therapeutics)
CTS3157
OPN-51107
DM5167
Euregen MAT2Ais
PODO83
YAP/TAZ-TEAD抑制剂
PW1087
PW0965
FGFR4,CD276双靶向CAR-T
KX147
PAR2抑制剂(Domain)
Integrin αvβ3靶向CAR-T(Virginia)
重组抗BCMA和CD3双特异性抗体（华兰）
四硫钼酸铵
贝伐珠单抗生物类似药 (Celltrion)
CD318靶向CAR-T(美天旎)
重组抗CD38人源化单克隆抗体 (杭州尚健)
利妥昔单抗生物类似药 (丽珠医药)
靶向CD19的嵌合抗原受体基因修饰的NK细胞（上海先博）
WT508
WT702
WT203
FT-522
Recombinant anti-PD-L1 and TGF-β bifunctional fusion protein (Hualan Genetic)
WT105
AP-L1748
B7-H3-CAR T cells(St. Jude Children's Research Hospital)
BI-1821736
ATX-03
Brimarefenib
HRO-761
TG-01(Targovax)
B4T2-002
PM-54
SHR-2017
SAR445514
Bevacizumab biosimilar (mAbxience)
GS-4528
ISM-3091
YL-212
Vepdegestrant
Ruvidar
Ipilimumab biosimilar (Innovent Biologics)
APX3330
VT-EBV-N
HLX-208
JS-002 (Shanghai Junshi)
ZKAB-001/Icaritin(Lee’s Pharmaceutical/Shenogen Pharma Group)
Isoquercetin
Nadroparin Calcium
TC-520
BM2052
Poke-101
CLR-125
FTX-301
CL04183
BEN-101
PET-ONCO
Gavo-cel (TCR2 Therapeutics)
EscharEx
68Ga-DOTA/NOTA-FAPI-04
Esuberaprost Sodium
Poke-103
AZ-M015
NSI-2
PRX-119
MG-D-2020
Doxorubicin Hydrochloride/Sodium Hyaluronate
5 Peptide Cocktail Vaccine
OC201+OC202e
JY-016
Metablok
Poke-102
Anti-mesothelin CAR T-cell therapy(National Cancer Institute)
HPK1 inhibitors(AZ)
Nectin-4/CD3 targeted bispecific antibody
90Y-NM600
Cbl-b inhibitors(Simcere Pharmaceutical)
CD20 and CD19 dual-targeting CAR-T cells(Miltenyi Biotec)
ZY19
BCG-033
KGX201
Allogeneic CD19-directed CAR-iNKT cells(Arovella)
Quaratusugene ozeplasmid
BCMA/GPRC5D dual targeting CAR-NK(Shanghai Simnova Biotechnology)
rPOC-0752/0754
IDO1/TDO2 inhibitors(Idorsia Pharma)
ENPP1 inhibitors(LegoChem Biosciences)
PD-1/IL-7 targeted bispecific antibody(OSE)
TAG72 inhibitors CAR T(City of Hope)
DLL3/CD3/CD137 trispecific T cell engager(Chugai Pharmaceutical)
PARP1 inhibitors(Duke Street Bio)
PARP7 inhibitors(Duke Street Bio)
PRMT5 inhibitors(Ryvu Therapeutics)
SHP2 inhibitors(kanaph Therapeutics)
A2AR inhibitors(Aurigene)
RNF31 inhibitors(IQS)
LILRB1/LILRB2 targeted bispecific antibody(OncoResponse)
Cyclin A/B inhibitors(Circle)
APP targeted antibody(Genome & Company)
Rb10
IL-22 targeted monoclonal antibody(BioAtla)
BSA-01
CD19 targeting CAR-NK(Charles River)
LGR5 targeting CAR-T(Adelaide)
β-catenin peptide inhibitors(FogPharma)
Microtubule inhibitors(BERG)
GT1708F
225Ac-NM600
GPX4 inhibitors(Sonata Therapeutics)
Rb9
CEACAM1 targeted antibody(NeoLogics)
HER2/CD3 targeted antibody(BioAtla)
rPOC-752
GPC1 targeted VHH nanobody CAR-T(NIH)
Siglec-6/CD3 targeted bispecific antibody(OSU)
Fully human internalizing anti-Her2 monoclonal antibodies(A&G Pharmaceutical)
STARD5 inhibitors(Virginia Commonwealth University)
Anti-CEACAM5 ADC(Sanofi)
GPX4 inhibitors(Arpeggio)
CTLA-4/STAT3 aptamer-siRNA chimera
iPSC-derived NK cells with TGFβR2 knock-out and/or IL-15 knock-in(Cellectis)
PD-L1 targeting CAR-T(VaxCell)
FOLR1 targeting CAR-T(Miltenyi Biotec)
CD44v6 targeting CAR-T(Go Therapeutics)
YAP/TAZ-TEAD inhibitors
FGFR4/CD276 dual targeting CAR-T
PAR2 inhibitors(Domain)
Integrin αvβ3 targeting CAR-T(Virginia)
Edralbrutinib
ABC-0609
ABC-1123
OBX09 Series
ADCT-211
NRT-NMJ_001
OBX02 Series
XS-04
OBX18 Series
BPT-567
AMC4
LM-24C5
[18F]SF-DEVD-2
OBX13 Series
BPI-221351
CPD-1224
ZhyperPrime
LX-101
AMC1-NK cells
NRT-YHD_002
Mag-I
ABC-0942
NRT-NMJ_002
ABC-1103
NRT-YHD_001
OBX08 Series
ABC-0222
OBX16 Series
NRT-KSY_001
NRT-YHD_003
ABC-0996
SCG101
MARU-301
NRX-NGT-001
PCV-001
BCG-022
MARU-103
NRX-NGT-007
KMD-120
BDB-101
KMD-110
NRX-GT-002
Zabadinostat
NRX-GT-001
MARU-203
AT-101
MARU-201
RCT1213
NRX-NGT-008
MARU-102
KMD-140
MARU-101
SAB-162
HPT-102
MARU-202
RCT2133
Ammonium tetrathiomolybdate
GT90008
INB 200(IN8bio)
7E1
GI-102
Tasurgratinib
RK001
6B5
LXD191
DAAN-004
EGFR2 inhibitors (Shenzhen Forward Pharmaceuticals)
AT-04(Antharis Therapeutics)
JG-2016
AT-01
RK002
MD102(MD biopharma)
AL-801DX
MD200
OVV-3
DAAN-001
64B
GT-919
OVV-2
DAAN-002
AT-06(Antharis Therapeutics)
BIO103
AT-12
MD300
AT-07
OVV-5
AT-03(Antharis Therapeutics)
XIN5104
AT-04(Axcynsis Therapeutics)_COPY
BIO104
XIN6301
KRAS G12D inhibitors (Shenzhen Forward Pharmaceuticals)
LPT-101
AT-10
XS-02
AT-09
AT-08
177Lu-NM600
AT-05
DAAN-005
BIO105
DAAN-003
AT-11
XIN5789
AT-00
BIO107
BIO106
AT-03(Axcynsis Therapeutics)
[18F]NT160
OVV-4
AT-02(Antharis Therapeutics)
AL-801
BIO101
ETN101
SynKIR-110
Bevacizumab biosimilar (Celltrion)
O-(2-[18F]fluoroethyl)-L-tyrosine
CD318 targeted CAR-T
CL-03
h14A043-ATAC
CAR.B7-H3T cells(UNC Lineberger Comprehensive Cancer Center)
177Lu-LNC1010
ART-200
NEOG-100
ART-100
CYT-103(Cytovia Therapeutics)
NEOG-3000
Recombinant human anti-CD38 momoclonal antibody(Hangzhou Sumgen)
Recombinant human anti-VEGFR2 monoclonal antibody(Shandong Buchang)
ISM-6466A
NEOG-4000
ART-300
177Lu-HER3 ARC
AST-006 (Ascentawits)
ISM-3412
CD123-CAR T Cells(St. Jude Children's Research Hospital)
SYS-6010
FWB-2114
FWB-19144
FWD-1509
Itacnosertib
Camrelizumab(Jiangsu Hengrui Medicine Co. Ltd.)
Rituximab Biosimilar (Livzon)
CLS-002
ABD-147
iPSC-CAR-M(SNC Stem Cell)
68Ga-FAPI-04
GSK4381562A
NWRD06裸质粒DNA
曲妥珠单抗生物类似药(MiGenTra)
靶向GPRC5D嵌合抗原受体自体T细胞（原启生物）
贝伐珠单抗生物类似药 (Nichi-Iko Pharmaceutical)
贝伐珠单抗生物类似药 (信达生物)
贝伐珠单抗生物类似药(神州细胞工程)
利妥昔单抗生物类似药(Sando)
贝伐珠单抗生物类似药 (东方百泰)
TL-118 (Teligene)
MGT-2201
PVTX-405
GLPG-5301
RGN-6024
EVOLVE-106
AUR-107
CYNK-302
FMS like tyrosine kinase 3 inhibitor(TargetRx)
TTX-564
SP-1-303
BBRP-11031
THRYV-1257
IAB-56
CMN-008
YH-016
BCG-012
KIN-201
AKi
61Cu-based CuNeo radiodiagnostic(Nuclidium)
LNTH-1558
AUTL-01
TC-221
HHPR
ENOB DC 12 XX
BCG-006
MCT-101
INV-X
SIM-0361
61Cu-based AlphaFlare radiodiagnostic(Nuclidium)
CBRX-101
ADAP-01
JS-208
BBRP-11021
HLX-80
BCG-011
IBIO-301
HLX-41
APB-R8
NWRD06
HHTP
61Cu-based TraceNET radiodiagnostic(Nuclidium)
HHPM
F2i
Trastuzumab biosimilar(MiGenTra)
NG-XXX
STK-026
HLX-309
BCG-010
M4i
61Cu-based NuriPro radiodiagnostic(Nuclidium)
D-4559
KAN-571
MOD-B
DO-5
BA-1302
AB-2100
CYAD-03
61Cu-based Kalios radiodiagnostic(Nuclidium)
Anti-CD19 CAR-T cell therapy (Yake Biotechnology)
LAE-120
HLX-61
LAE-119
Stimotimagene copolymerplasmid
BCG-013
AAV-LIGHT
Mini-CAR 100
HS-218 alpha
MGT-2202
AG-102
Tumour infiltrating lymphocyte therapy(Lyell Immunopharma)
ALA-101
TTX-810
CYNK-301
Antisense oligonucleotide therapeutic(NanoCarrier)
CYCART-201
PVTX-321
GPR-15
TTX-114
Bruton's tyrosine kinase inhibitor(TargetRx)
PHIN-1314
DO-7
CD19-7×19 CAR-T plus PD1 monoclonal antibody(Second Affiliated Hospital, School of Medicine, Zhejiang University)
AST-201(Aptamer)
CM-110
EFIL-301
CM-109
Nelmastobart
EX-108
AUR-106
JYP-0061
EX-106
EX-107
MC150
Anti-CD19/CD22 CAR-T cell therapy (Chongqing Precision Biotech)
ISM-5939
Voraplasmid
QLS1103
Bevacizumab biosimilar (Nichi-Iko Pharmaceutical)
SLAMF7 FPBMC(University of Virginia)
ATLCAR.CD19
EX-104
Bevacizumab biosimilar (Innovent Biologics)
DCTY-0801
Vididencel
EX-105
KSP/QRH dimer
Bevacizumab biosimilar(Sinocelltech Group)
XmAb541
JH-02
JH-04
Pomiferin
Rituximab biosimilar(Sando)
Bevacizumab biosimilar (Eastern Biotech)
环磷酰胺
甲氨蝶呤
磷酸氟达拉滨
羟基脲
依托泊苷
替加氟
酒石酸长春瑞滨
卡培他滨
替吉奥
氟尿嘧啶
盐酸拓扑替康
去氧氟尿苷
卡莫氟
田参氨基酸
门冬酰胺
硫鸟嘌呤
盐酸伊达比星
美法仑
盐酸埃克替尼
白消安
西达本胺
转移因子
他莫昔芬
磷酸雌莫司汀
己烯雌酚
氟他胺
依西美坦
枸橼酸托瑞米芬
比卡鲁胺
来曲唑
醋酸甲羟孕酮
阿那曲唑
氨鲁米特
醋酸甲地孕酮
氮甲
甲磺酸奥希替尼
阿贝西利
来那度胺
吉非替尼
甲苯磺酸索拉非尼
盐酸厄洛替尼
苹果酸舒尼替尼
二甲苯磺酸拉帕替尼
甲磺酸伊马替尼
尼洛替尼
达沙替尼
甲磺酸阿帕替尼
甲苯磺酸拉帕替尼
芦可替尼
氟马替尼
哌柏西利
甲磺酸阿美替尼
盐酸恩沙替尼
奥布替尼
甲磺酸伏美替尼
卡博替尼
依维莫司
托烷司琼
阿扎司琼
昂丹司琼
格拉司琼
雷莫司琼
帕洛诺司琼
氯膦酸二钠
苯丁酸氮芥
乌苯美司
云芝胞内糖肽
亚叶酸钙
苦参素
去甲斑蝥素
利可君
阿瑞匹坦
洛莫司汀
克唑替尼
司莫司汀
六甲蜜胺
甲基斑蝥胺
氯氧喹
甲异靛
阿法替尼
凡德他尼
维莫德吉
甘磷酰芥
马蔺子甲素
大麻隆
斑蝥酸钠
乙双吗啉
瑞戈非尼
维莫非尼
伊沙佐米
阿帕他胺
维奈克拉
西罗莫司
炔雌醇
醋酸戈舍瑞林
格列本脲
匹多莫德
生物活性的多肽
盐酸小檗胺
含胸腺素α
甘露聚糖肽
健康牛胸腺提取含生物活性的多肽类物质
健康牛脾脏为原料
银耳多糖
胸腺肽
鲨肝醇
羧甲淀粉钠
维生素B
a-甘露聚糖肽
自新鲜猪脾脏中提取的多肽及核苷酸类物质
阿魏酸钠
茜草双酯
来氟米特
氧化苦参碱
环孢素
吗替麦考酚酯
本品主要成份及其化学名称为:盐酸雷莫司琼
盐酸雷莫司琼
硫酸羟氯喹
乌骨藤
沙利度胺
硫唑嘌呤
麦考酚酸
咪唑立宾
紫芝多糖粉
氯膦酸二钠四水合物
江西山香药业有限公司
顺铂
吉西他滨
多西他赛
替尼泊苷
卡铂
奥沙利铂
盐酸伊立替康
奈达铂
盐酸表柔比星
盐酸托泊替康
培美曲塞二钠
盐酸米托蒽醌
肠毒素C
盐酸多柔比星脂质体
硫酸长春地辛
氟脲苷
放线菌素D
盐酸柔红霉素
达卡巴嗪
盐酸尼莫司汀
羟喜树碱
克拉屈滨
盐酸博莱霉素
高三尖杉酯碱
地西他滨
洛铂
依那西普
盐酸氮芥
盐酸多柔比星
盐酸吡柔比星
长春花碱
醋酸奥曲肽
亮丙瑞林
硫酸长春新碱
醋酸曲普瑞林
雷替曲塞
福美坦
血卟啉
博安霉素
三尖杉酯碱
曲普瑞林
亚胺醌
盐酸槐定碱
抗肿瘤免疫核糖核酸
黄芪多糖
重组改构人肿瘤坏死因子
重组人血管内皮抑制素
尼妥珠单抗
薄芝糖肽
曲妥珠单抗
贝伐珠单抗
西妥昔单抗
硼替佐米
纳武利尤单抗
帕博利珠单抗
达雷妥尤单抗
度伐利尤单抗
替雷利珠单抗
卡瑞利珠单抗
唑来膦酸
氨磷汀
甘氨双唑钠
硝卡芥
盐酸博来霉素
新福菌素
盐酸阿柔比星
甲磺酸多拉司琼
羟基喜树碱
重组人粒细胞集落刺激因子
榄香烯
纳米炭
盐酸平阳霉素
重组人p53腺病毒
碘[I]美妥昔单抗
卡莫司汀
右丙亚胺
尿多酸肽
去甲斑蝥酸钠
氯化锶[Sr]
亚砷酸
重组人5型腺病毒
胶体磷[P]酸铬
因卡膦酸二钠
左旋门冬酰胺酶
安吖啶
福莫司汀
碘[131I]肿瘤细胞核人鼠嵌合单克隆抗体
磺巯嘌呤
卫矛醇
阿立必利
金葡菌毒素
双环铂
硫酸培洛霉素
去甲斑蟊酸钠
亚叶酸钠
油酸多相脂质体
白介素
枸橼酸托烷司琼
槲寄生
右雷佐生
伊尼妥单抗
普拉曲沙
贝林妥欧单抗
氯化镭[223Ra]
硫酸长春花碱
安西他滨
氟维司群
醋酸亮丙瑞林
重组人粒细胞刺激因子
A群链球菌
胸腺法新
人免疫球蛋白
α-甘露聚糖肽
破伤风人免疫球蛋白
人参多糖
重组人粒细胞-巨噬细胞集落刺激因子
重组人粒细胞巨噬细胞集落刺激因子
重组人白细胞介素-2
胸腺a
蛋白质中95%以上为免疫球蛋白
胸腺α
辅酶A
健康乳牛（出生24小时内）脾脏为原料提取而成
伤寒沙门氏菌培养液纯化的Vi多糖
从健康小牛胸腺中提取的胸腺α
重组人粒细胞巨噬细胞刺激因子
人血白蛋白
胸腺肽α1
重组人粒细胞刺激因子其来源
本品蛋白质中95%以上为免疫球蛋白
本品蛋白质中95%以上为人免疫球蛋白
抗人T细胞猪免疫球蛋白
复方制剂
4-羟基苯乙酸；5-羟基吲哚乙酸；苯乙酰谷氨酰胺；多肽；马尿酸
抗Tac单抗
巴利昔单抗
磷
阿达木单抗
苦参碱
甘露醇和氯化钠
左亚叶酸钙
喜树碱
多磺酸粘多糖
重组人干扰素
还原型谷胱甘肽
薏苡仁油甘油三酯
碘[I]
恩美曲妥珠单抗
曲美替尼
帕妥珠单抗
硼替佐米
达拉非尼
培唑帕尼
塞瑞替尼
尼拉帕利
地舒单抗
乙磺酸尼达尼布
维布妥昔单抗
本品主要成份为左氧氟沙星。
本品的主要成分为叶酸。
本品主要成分为布洛芬。
主要成份为：吡非尼酮
本品主要成份为波生坦。
本品主要成份为左氧氟沙星。
本品的主要成分为叶酸。
本品主要成分为布洛芬。
本品主要成份为枸橼酸西地那非。
本品主要成分为甘露醇。
本品主要成分为秋水仙碱。
本品主要成份为（醋酸）地塞米松。
本品主要成份为醋酸奥曲肽。
本品主要成分为瑞舒伐他汀钙。
本品主要成份为环孢素。
本品主要成分为盐酸胺碘酮。
本品主要成分为艾地苯醌。
本品主要成分为盐酸普拉克索。
本品主要成分为甲泼尼龙。
本品主要成分为巴氯芬。
本品主要成分为美沙拉嗪。
本品主要成份为西罗莫司。
本品主要成分为氨甲环酸。
本品各类制剂的主要成份为他克莫司。
本品主要成分为拉莫三嗪。
本品主要成份为加巴喷丁。
本品主要成分为盐酸司来吉兰。
本品主要成份为氨曲南。
本品主要成分为酮康唑。
本品主要成分为醋酸钙。
本品主要成分为D-3-巯基-缬氨酸。
本品主要成分为依达拉奉。
本品主要成分为吡非尼酮。
本品主要成分为左乙拉西坦。
本品主要成分为色甘酸钠。
本品的主要成分为乙磺酸尼达尼布。
本品主要成分为英夫利西单抗。
本品主要成分为甲磺酸雷沙吉兰。
本品主要成分为托吡酯。
本品主要成份为人单克隆免疫球蛋白G2（IgG2）。
本品主要成分为阿巴西普。
本品主要成分为利鲁唑。
本品主要成分为达那唑。
本品主要成份为诺西那生钠。
本品主要成分为去醋酸氨加压素。
本品主要成分为妥布霉素。
本品主要成份为地拉罗司。
本品主要成份为波生坦。
本品主要成分为甲状旁腺激素。
本品主要成份为盐酸罗匹尼罗。
本品主要成分为亚甲蓝。
本品主要成分为依那西普。
本品主要成分为醋酸亮丙瑞林。
本品主要成份为特立氟胺。
本品主要成分为吡贝地尔。
本品主要成分为左旋多巴。
本品主要成分为氨己烯酸。
本品主要成分为醋酸锌。
本品主要成分为溴吡斯的明。
本品主要成分为戈利木单抗。
本品主要成分为吗替麦考酚酯。
本品主要成分为依库珠单抗。
本品主要成分为醋酸兰瑞肽。
本品的主要成分为利奥西呱。
本品主要成分为促皮质素。
本品主要成分为恩他卡朋。
羟丁酸钠注射液：本品的主要成分为羟丁酸钠。
本品主要成份伊洛前列素。
本品主要成分为司妥昔单抗。
本品主要成分为盐酸美西律。
本品主要成分为司替戊醇。
本品主要成分为培维索孟。
本品主要成分为卢非酰胺。
本品主要成分为艾替班特。
本品主要成分为去铁酮。
本品主要成分为氘代丁苯那嗪。
本品主要成分为丁苯那嗪。
本品主要成分为美曲普汀。
本品主要成分为甲磺酸洛美他派。
本品主要成分为盐酸阿那格雷。
本品主要成份为重组凝血因子Ⅸ。
本品主要成分为重组凝血因子Ⅶa。
本品主要成分为林伐美卡舍明。
本品主要成分为安立生坦。
本品主要成分为利鲁唑。
本品主要成分为安立生坦。
本品主要成份为醋酸亮丙瑞林。
本品是由GC1菌株经液体发酵培养法制得的灵芝属薄树芝[Ganoderma capense（Lloyd ）Teng］干燥菌丝体粉末中提取制得的灭菌水溶液。其组分为多糖和多肽。
本品是由GC1菌株经液体发酵培养法制得的灵芝属薄树芝干燥菌丝体粉末中提取制得的灭菌水溶液。其组分为多糖和多肽。
本品主要成份重组人干扰素β-1b。
本品主要成分为二盐酸沙丙蝶呤。
本品主要成分为他达拉非。
本品主要成分为托珠单抗。
本品主要成分为芬戈莫德。
本品主要成分为盐酸半胱胺。
本品主要成分为盐酸硫胺素。
本品主要成分为抗坏血酸钠。
本品主要成分为左卡尼汀。
本品主要成分为乙氨醇艾曲波帕。
本品主要成分为阿达木单抗。
本品的主要成分为马昔腾坦。
本品主要成份为曲前列尼尔。
本品主要成分为干扰素γ-1b。
本品主要成份为托伐普坦。
地塞米松棕榈酸酯
本品主要成份是托伐普坦。
主要成分为亚甲蓝
醋酸去氨加压素。
主要成份为∶吡非尼酮
主要成份为特立氟胺。
本品的主要成份为西罗莫司。
活性成份为阿加糖酶β
本品是由GC1菌株经液体发酵培养法制得的灵芝属薄树芝[Ganoderma capense
（Lloyd ）Teng］干燥菌丝体粉末中提取制得的灭菌水溶液。其组分为多糖和多肽。
活性成份：恩他卡朋
化学名称：N-2-炔丙基-1(R)--氨基茚甲磺酸盐
本品主要成份为利鲁唑
本品活性成份为诺西那生钠。
本品主要成份：盐酸普拉克索。
本品主要成份为盐酸普拉克索。
（-）-N-（1-苯基异丙基）-N-甲基-N-丙基-氯化胺
本品的主要成份为盐酸司来吉兰
主要活性成分：托珠单抗
活性成份：巴氯芬
本品主要成份为∶溴吡斯的明
本品主要成份为艾地苯醌
化学名称：吡贝地尔
主要成份：拉那利尤单抗
本品主要成份为：氯苯唑酸
本品主要成分为：氯苯唑酸葡胺
本品活性成份：司来帕格
本品主要成份为：利奥西呱
活性成分：阿达木单抗40mg。辅 料：枸橼酸钠；枸橼酸；磷酸二氢钠；磷酸氢二钠；蔗糖；聚山梨酯80；氢氧化钠
本品主要成份及化学名称为：醋酸兰瑞肽。
本品主要成分为亚甲蓝。
本品主要成分为艾地苯醌。
本品主要成份为艾地苯醌。
活性成份为阿加糖酶β。
本品主要成分为氘代丁苯那嗪。
本品主要成分为地夫可特。
本品为主要成分为免疫球蛋白。
本品主要活性成分为重组利妥昔单抗。
本品主要成分为环磷酰胺。
本品主要成分为米托蒽醌。
本品主要成分为那他珠单抗。
本品主要成分为C1酯酶抑制剂。
本品主要成分为盐酸金刚烷胺。
本品的主要成分为艾曲泊帕乙醇胺。
本品主要成分为依泊汀-θ。
本品主要成分为硫唑嘌呤。
本品主要成份为甲氨蝶呤。
本品主要成分为奥氮平。
本品主要成分为利培酮。
本品主要成份为阿立哌唑
本品主要成分为氟哌啶醇。
本品主要成分为盐酸氟奋乃静。
本品主要成份为氨曲南。
本品每20 ml溶液含：活性成分：西妥昔单抗 100 mg其它成分：氯化钠 116.88 mg；甘氨酸 150.14 mg；聚山梨酯80 2 mg；一水合柠楼酸 42.02 mg；氢氧化钠(1M) 调节PH直至55；注射用水 加至20 ml。
本品主要成分为西妥昔单抗。
本品主要成份为来那度胺。
活性成份：艾曲泊帕乙醇胺。
活性成分：Elosulfase alfa是利用重组DNA技术由中国仓鼠卵巢（CHO）细胞表达制备的重组人N-乙酰半乳糖胺-6-硫酸酯酶（rhGALNS）。
活性成份：利司扑兰（risdiplam）
活性成分：重组人类酸性 α-葡萄糖苷酶
活性成份：艾美赛珠单抗
活性成分：拉罗尼酶
本品主要成份为伊米苷酶。
本品主要成分为麦格司他。
本品主要成份为：醋酸泼尼松龙。
本品主要成份为：甲泼尼龙琥珀酸钠。
本品主要成份为：甲泼尼龙
活性成分：奥氮平
化学名称：奥氮平
活性成份：利培酮
本品主要成份为（醋酸）地塞米松。
羟丁酸钠注射液：本品的主要成分为羟丁酸钠。
3饿
盐酸普拉克索
主要成分：酸去氨加压素
本品主要成份：醋酸钙
本品主要成份: 羟丁酸钠
主要成份为巴氯芬。
活性成份：巴氯芬。
本品化学名称为：羟基脲
本品主要成份为安立生坦。
化学名称：(+)-(2S)-2-[(4,6-二甲基嘧啶-2-基)氧基]-3-甲氧基-3,3-二苯基丙酸
本品是由GC1菌株经液体发酵培养法制得的灵芝属薄树芝[Ganoderma capense（Lloyd ）Teng]干燥菌丝体粉末中提取制得的灭菌水溶液。其组分为多糖和多肽。
去铁酮。
主要成份：美沙拉秦
本品主要成分：美沙拉秦。
化学名称：5-氨基水杨酸
本品活性成份：马昔腾坦
艾度硫酸酯酶β
本品主要成分为卡比多巴和左旋多巴。
主要成分：达依泊汀 α
本品主要成份为盐酸金刚烷胺。
本品主要成分为盐酸金刚烷胺。
本品主要成份是甲氨蝶呤
本品主要成份为甲氨蝶呤。
本品主要成份为利培酮。
本品主要成分为拉莫三嗪
本品主要成份为环孢素。
活性成分：依库珠单抗是采用重组 DNA 技术由鼠源骨髓瘤细胞系 NS0 细胞表达制备的抗人补体蛋白 C5 人源化单克隆抗体（IgG2/4κ）。
辅料: 磷酸二氢钠
磷酸氢二钠
氯化钠
聚山梨酯 80
注射用水
本品活性成份为磷酸芦可替尼。
本品主要成份为沙利度胺。
本品主要成份为加巴喷丁
本品主要成份为硫唑嘌呤。
本品主要成份为他克莫司。
本品主要成份为癸氟奋乃静。
本品主要成份为氟哌啶醇。
本品主要成份为左旋多巴。
本品主要成份：卡马西平
本品的主要成份为苯妥英钠。
本品主要成份为奥卡西平。
本品主要成份为青霉胺。
本品主要成份：硫酸锌
本品主要成份为阿立哌唑。
本品主要成份为丙戊酸钠。
本品主要为替硝苯那嗪
丁苯那嗪
阿伦单抗
西尼莫德
芬戈莫德
本品主要成分为癸氟奋乃静。
本品主要成分为卡马西平。
本品主要成份为苯妥英钠。
本品主要成分为奥卡西平。
本品主要成分为丙戊酸钠。
苯巴比妥
本品主要成分为酮康唑。
测试
定位
本品主要成份为安立生坦
本品活性成份：马昔腾坦
司妥昔单抗。
重组人凝血因子Ⅷ。
盐酸沙丙蝶呤。
万他维主要成分为伊洛前列素。
瑞莫杜林主要成分曲前列尼尔。
艾思瑞主要成份为：吡非尼酮。
本品主要成份为：乙磺酸尼达尼布
重组人干扰素。
本品活性成份为帕米膦酸二钠。
本品主要成分为甲泼尼龙。
本品主要成份为加巴喷丁。
本品主要成分为依达拉奉。
本品主要成分为溴吡斯的明。
本品主要成分为依库珠单抗。
本品主要成份为重组凝血因子Ⅸ。
本品主要成分为环磷酰胺。
本品主要成分为硫唑嘌呤。
本品主要成份为环孢素。
本品各类制剂的主要成份为他克莫司。
本品主要成份为特立氟胺。
本品主要成分为吗替麦考酚酯。
本品主要成分为丁苯那嗪。
本品主要成份重组人干扰素β-1b。
本品主要成分为芬戈莫德。
本品为主要成分为免疫球蛋白。
本品主要活性成分为重组利妥昔单抗。
本品主要成分为米托蒽醌。
本品主要成分为那他珠单抗。
本品主要成分为奥氮平。
本品主要成分为氟哌啶醇。
本品主要成分为癸氟奋乃静。
本品主要成份为西罗莫司。
本品主要成分为D-3-巯基-缬氨酸。
本品主要成份为诺西那生钠。
本品主要成分为左旋多巴。
本品主要成分为醋酸锌。
本品主要成份为甲氨蝶呤。
本品主要成分为卡马西平。
本品主要成份为苯妥英钠。
本品主要成分为丙戊酸钠。
主要成分托吡酯。
本品主要成分为瑞舒伐他汀钙。
本品主要成份为人单克隆免疫球蛋白G2（IgG2）。
本品主要成份伊洛前列素。
本品主要成分为司妥昔单抗。
本品主要成分为甲磺酸洛美他派。
本品主要成分为二盐酸沙丙蝶呤。
主要成分依维莫司。
本品主要成份为瑞舒伐他汀钙。
主要成分为洛美他派。
米泊美生
本品主要成分为吡非尼酮。
本品的主要成分为乙磺酸尼达尼布。
本品主要成份为曲前列尼尔。
本品主要成分为布洛芬。
本品主要成份为枸橼酸西地那非。
本品主要成份为醋酸奥曲肽。
本品主要成分为美沙拉嗪。
本品主要成分为氨甲环酸。
本品主要成分为醋酸钙。
本品主要成分为色甘酸钠。
本品主要成分为英夫利西单抗。
本品主要成分为去醋酸氨加压素。
本品主要成分为妥布霉素。
本品主要成份为地拉罗司。
本品主要成分为依那西普。
本品主要成分为氨己烯酸。
本品主要成分为戈利木单抗。
本品主要成分为司替戊醇。
本品主要成分为培维索孟。
本品主要成分为去铁酮。
本品主要成分为美曲普汀。
本品主要成分为盐酸阿那格雷。
本品主要成分为重组凝血因子Ⅶa。
本品活性成份为氨吡啶
本品主要成分为甲泼尼龙琥珀酸钠
本品主要成分为醋酸亮丙瑞林。
本品主要成分为盐酸普拉克索。
本品主要成分为甲磺酸雷沙吉兰。
主要成分为他达拉非。
枸橼酸西地那非。
本品主要成分为艾替班特。
本品主要成分为左卡尼汀。
本品主要成份为海曲泊帕乙醇胺
本品主要成分是左卡尼汀
E-氨甲环酸
本品主要成分为盐酸司来吉兰。
色甘酸钠
本品主要成分为妥布霉素
本品主要成份为地拉罗司。
本品主要成分为醋酸兰瑞肽。
本品是由GC1菌株经液体发酵培养法制得的灵芝属薄树芝干燥菌丝体粉末中提取制得的灭菌水溶液。其组分为多糖和多肽。
本品主要成分为乙氨醇艾曲波帕。
本品主要成分为美曲普汀。
艾曲泊帕乙醇胺
本品主要成分为C1酯酶抑制剂。
本品主要成分为秋水仙碱。
本品主要成份为更昔洛韦。
华法林钠。
本品主要成份为 2-（乙酰氧基）苯甲酸。
本品含氯化钾(KCl) 应为标示量的95.0％～105.0％。
螺内酯
本品主要成分为碳酸氢钠
本品主要成分及其化学名：本品主要成分为达那唑。
本品每片含门冬氨酸钾(C4H6NO4K)158mg和门冬氨酸镁[(C4H6NO4)2Mg]140mg。
本品主要成份对乙酰氨基酚。
盐酸吡多醇。
主要成分为富马酸喹硫平。
盐酸精氨酸。
骨化三醇
十一酸睾酮。
戊酸雌二醇。
本品是前列环素(PGI2)的衍生物。
化学名称为:3α,7β-二羟基-5β-胆甾烷-24-酸。
醋酸环丙孕酮。
维生素B1。
醋酸甲羟孕酮。
本品主要成分为来曲唑。
本品主要成分为格列本脲。
硫酸新霉素。
本品主要成份为：阿奇霉素。
主要成分为盐酸环丙沙星。
本品化学名称为：硫酸长春新碱。
主要成分：依托泊苷。
本品主要成份地西泮。
主要成分为考来烯胺。
本品主要成分为盐酸金刚烷胺。
奎扎替尼
曲美木单抗
喷他脒依西酸盐
钆喷酸葡胺
重组人源化抗表皮生长因子受体单抗(上海津曼特生物科技有限公司)
阿维A酯
莱古杉醇
莱古比星
K333抗体 (绿竹生物)
重组人源化抗BTLA单克隆抗体
重组抗EGFR人鼠嵌合单抗 (上海三生国健)
阿维A
双氯芬酸钠
塞来昔布/奥美沙坦
醋酸甲泼尼龙
纳武利尤单抗生物类似药 (山东博安生物)
地舒单抗生物类似药 (山东博安生物)
贝伐珠单抗生物类似物 (山东博安生物)
盐酸吉西他滨
Quizartinib Hydrochloride
Orelabrutinib
HLK-1008
LM-005
HLK-1007
CID-103
IMD511
IMD-917
LM-008
Trilostane
QHL-506
IMD-605
LM-009
LM-003 (LaNova Medicine)
LM-002 (LaNova Medicines)
BP-1002
IMD101
LM-006
IMD-1618
APX-3330
GT202
Pentamidine Isethionate
Flutamide
Carboplatin
ZN-C3
LM-007 (LaNova Medicines)
QHL-1031
CBP/p300 Program(Proteovant Therapeutics)
ZN-B-2262
QHL-1231
Gadopentetate Dimeglumine
KRAS G12D Program(Proteovant Therapeutics)
STAT3 Program(Proteovant Therapeutics)
JMT-101(Shanghai Jinmante Biological Technology Co Ltd)
NMK-89
Eculizumab biosimilar (AffaMed Therapeutics)
Etretinate
CG-001419
IMD303
SMARCA2/4 Program(Proteovant Therapeutics)
Legutaxel
AR Program(Proteovant Therapeutics)
Legubicin
K333 (Luzhu Biotech)
Etoposide
QHL-625
Tifcemalimab
EK193
D-1553
LM-001(LaNova Medicines)
Recombinant anti-EGFR chimeric monoclonal antibody(Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd.)
QHL-718
Acitretin
JMT-601
QHL-339
LM-004 (LaNova Medicine)
Diclofenac Sodium
QHL-816
Celecoxib/Olmesartan
Q-702
CX-1026
AL-2846
Merestinib
Methylprednisolone Acetate
HXYT-001
Nivolumab Biosimilar (Shandong Boan Biological)
Denosumab Biosimilar (Shandong Boan Biological)
PR-301
Bevacizumab Biosimilar (Shandong Boan Biological)
Gemcitabine Hydrochloride
AnxA5MOD-TNFa
ARX-050
SKB-264
癌症治疗用重组人表皮生长因子（EGF）偶联疫苗(Biotech Pharmaceuticals Pty Ltd)
抗CD19 CAR-T细胞疗法(Juno Therapeutics, Inc.)
乙烷硒啉
20(S)-人参皂苷Rg3
爱普列特
醋酸美替诺龙
靶向CD22嵌合抗原受体T细胞疗法 (武汉波睿达生物)
炔雌醇环丙孕酮
溴地斯的明
亚叶酸钙/氟尿嘧啶
美他非尼
马蔺子素
加莫烯酸
L-天冬酰胺酶 (Claris Lifesciences Ltd.)
依诺他滨
酪丝缬肽
程序死亡受体1敲减的靶向CD19嵌合抗原受体工程化T细胞 (上海优卡迪)
依铂
肾细胞癌疫苗(Fbm-Pharma)
程序死亡受体1敲减的靶向CD269嵌合抗原受体工程化T细胞 (上海优卡迪)
HD CD19 CAR-T细胞 (上海道生物医药)
2,4-二硝基氯苯
MDM2蛋白降解剂
靶向CD33嵌合抗原受体T细胞疗法 (武汉波睿达生物)
己酸孕诺酮
血卟啉醚酯
注射用红色诺卡氏菌细胞壁骨架(福建省山河药业有限公司)
紫杉醇/利托那韦
重组人血管内皮生长因子受体-抗体融合蛋白 (山东博安生物)
羧胺三唑
YZJ-0673马来酸盐
抗PSMA CAR-T细胞疗法(Sorrento Therapeutics, Inc.)
重组乙型肝炎疫苗(酿酒酵母)(GlaxoSmithKline Plc)
泼尼莫司汀
雷贝拉唑钠/克拉霉素/阿莫西林
因诺卡替-19细胞
重组细胞因子基因衍生蛋白(Genova, Inc.)
度格列汀酒石酸盐
盐酸贝洛替康
抗CD123嵌合抗原受体T细胞疗法 (上海吉凯基因)
PD-1基因定制活化T细胞
重组人血管内皮生长因子受体-抗体融合蛋白 (成都康弘生物)
重组柯萨奇病毒B3
盐酸博安霉素
HER2癌症疫苗(Pevion Biotech AG)
硫酸培来霉素
磷霉素钠
酪丝亮肽
溴新斯的明
WT1多肽疫苗(Osaka University)
地塞米松/硫酸奈替米星
A群链球菌 (武汉生物制品研究所)
甲苯磺酸艾力替尼
双环醇
迈华替尼
雷公藤内酯
磷雌酚钠
治疗卡介苗
熊果酸
氢醌
紫杉肽
L-天冬酰胺酶(Chandra Bhagat Pharma Ltd.)
靶向CD30嵌合抗原受体T细胞疗法 (武汉波睿达生物)
复方硫酸铝
信立他赛
槲皮素
丙戊酸/泼尼松
四氢尿苷
盐酸罗沙替丁醋酸酯
门冬酰胺酶(Pharmedic Laboratories Pvt Ltd.)
重组人内皮抑素腺病毒(成都恩多施生物工程技术有限公司)
抗CD22嵌合抗原T细胞疗法 (上海吉凯基因)
喷他霉素
靶向CD19嵌合抗原受体T细胞疗法 (武汉波睿达生物)
戈洛莫德
酒石酸长春氟宁
阿莫西林/甲硝唑/富马酸伏诺拉生
白介素6分泌功能敲减的靶向CD19自体基因编辑T细胞 (上海优卡迪)
盐酸法倔唑
拉多替尼二盐酸盐
希明哌瑞
腺嘌呤
倍他替尼
CS-3003
FWD-1802
BJRX-R06
BNT-153
GC-007F(Gracell Biotechnologies)
DC-Ad-CCL-21 intratumoral therapy(U.S. Department of Veteran Affairs)
NHWD-870
CT-1(Cannabis Science, Inc.)
GMC-1
KI-1102
YH-BIO-4
IMM-201
JAB-200
HYGT-110
J-pharma-002
TAS-1553
BLYG-8824
PF-06840003
Oba-01
HL-301
EC-8047
ZK-010
GT-10
BAY-1436032
JG-03-14
AVA-020
INCB-081776
TUL-001
MUC1-Poly-ICLC
ios H4
JAB-16000
MPT-0118
6-melanoma helper peptide vaccine(University of Virginia Foundation)
Anti-DR5 CAR-T cell therapy(DeHe Biotech (Energae))
Cellgram-DC
STTG-019
LRPAP1 synthetic long peptide(Erasmus University Medical Center Rotterdam)
Charis 1000
YH-BIO9
Copper Gluconate
siRNA-EphA2-DOPC
STM-418
PJ017
CRC-02
GB-1275
Human papillomavirus vaccine(Bioleaders Corp.)
COF-008
TL-895
SG-101
SB-02024
HW-130
Mobilan
Pexmetinib
EU-103
Anticancer therapeutics(Verseau Therapeutics, Inc.)
GMI-1687
BPT-143
CR-13626
GL-ONC3
ICT-140
JAB-17000
AT-1616
CS-23546
IMP-09
AFM-32
JSKN-005
RMC-5845
OP-09
CpG-ODN(K3)
Multi-epitope HER2 peptide vaccine(Mayo Clinic)
ASP-4132
FLAG-347
HPK1 targeting PROTACs drug
ZS/DC S015 dendritic cell vaccine (Zhongsheng Kangyuan Biotechnology)
T-1101
STTG-002
Small interfering RNA therapeutics(Yuhan Corp.)
TSC-201
Personalised melanoma cancer therapy ( BriaCell Therapeutics)
Recombinant human EGF conjugated vaccine(Biotech Pharmaceuticals Pty Ltd)
KD-030
Vistusertib
PRX-004
TLPO-001
LYN-00102
BP-1101
J2H PROTAC
BNT-152
MDNA109-LA2
Camptothecin(Calando Pharmaceuticals, Inc.)
Immune-based therapeutics(Phigenix, Inc.)
YMH-1007
BS-HH-002
Brain cancer vaccine(University of Pittsburgh Medical Center)
TT-228
VZV-specific-GD2-CAR
Anti-CD19 CAR-T cell therapy(Juno Therapeutics, Inc.)
WIF-1906
BPI-17509
HGP-1163
IMA-101
SHS-002
Hemay088
ADPT-01
AU14-5
Ethaselen
CG-428
PCDC
CXD-201
OR-2299
VAX-DC/MM(Vaxcell-Bio Therapeutics)
DPV-003
KD-197
BP-101(BioMap)
AB-248
CTB-101
CYT XXXX
ML-901
FWB-1901
MPD-001
RNA 4TNBC
RAS-F3
PRT-1419
Tumour associated peptide antigen pulsed dendritic cell product
CB-401
TRQ-1501
Acalisib
19H6 hu - 3sBio
AUTO-8
Immuno-STAT targeting KRAS G12V (Cue Biopharma)
Nek2 siRNA therapy(Nagoya University)
CLX-ONC-5516
ICT-107
T cell vaccine AlloStim (Immunovative Therapies)
ND-2158
RD-14
LY-3023414
ACTR-707
Dendritic cell-tumor cell hybrid vaccine(Genoa Biotecnologia SA)
QP-EN2
HCW-9201
HER.CAR-CMV-specific-CTLs
GSK-3845097
bacTRL 1L 12
BDTX-507
OMT-111
GI-10N
Dorgenmeltucel-L
rQNestin 34.5
GLB-2005
D2C7-based immunotoxins(Istari Oncology, Inc.)
Cellspan oesophageal implant (Biostage)
GNC-T03
AST-023
GP 01 (GPCR Therapeutics)
HY-008
ABP-431
ASP-1570
RD-126
Acyline
PRO-1172
ONCOS-212
SYHA1801
SNP-162
IMM-101
NG-641
CC-671
ML-109
HRS-8807
CMLVAXb2a2-25
ZS/DC P011 dendritic cell vaccine (Zhongsheng Kangyuan Biotechnology)
BKX-002
OP-08
AU2-85
TYG 300
AZD-0095
NSC-706744
BLH1-13I
20(S)-Ginsenoside-Rg3
RAD-140
HER2(EQ)BBzeta/CD19 T cells(Mustang Bio, Inc.)
APG-3526
VT-EBV(ViGenCell, Inc.)
YHC-1104
CTL DISC 01
CPI-1
Epristeride
ARV-1803
Dendrogenin A
NTX-303
CD20-CD19 cCAR T cell therapy(iCell Gene Therapeutics, Inc.)
ATLCAR.CD138(Lineberger Comprehensive Cancer Center)
TQB-3602
TVAX cancer vaccine
AB-474
XTX-301
BCI-1415
Personalised lung cancer therapy ( BriaCell Therapeutics)
BLNP-008
CLN-617
NCB-001
VERU-100
YE-NEO-011
APTO-253
YHC-1107
YBL-015
STP-1002
XON-03
IMT-18
LHC-165
XRD-0394
Neumonco (Pneumagen)
OMT-110
EP-401
SiRNA oncology therapeutics(Verseau Therapeutics, Inc.)
SI-M005
LYN-00204
18F-Fluoromethylcholine
TransCon-TLR-7/8-agonist
ACIT-1 cancer vaccine
BPI-21000
CLT-030
ITI-1020
ABBV-992
Vigil Lung ( Gradalis)
YH-BIO3
FP-002
MAX-6
NEO-1132
LODO-141
BPI-22000
KTH-222
HH-2301
OXU 003
AMXT-1501
NEO-PV-01
KTX-475
KD-U207
MBS8(MonTa Biosciences ApS)
EPIM-001
K-476
CYAD-103
SHR-1909
Mopidamol
MDC-2060
ENO-3001
NeoCura IM-002
Metenolone Acetate
AT-1413
Recombinant HSP-MUC1 fusion protein(Shanghai Xinshengyuan Biological Medicine Co. Ltd.)
Peptide subunit vaccine(Eberhard Karls Universitat Tubingen)
WT1 peptide vaccine(The University of Chicago)
ROR1 TriKE (GT Biopharma)
agenT-842
CD33-NKE
Anti-CD19 CAR-T cell therapy(Aikangd Biomedical Technology (Suzhou) Co Ltd)
OR-3007
Anti-CTLA4 scfv producing Bifidobacterium longum (Anaeropharma Science)
KD-U197
NMS-03592088
Hematopoietic progenitor cell marrow therapy (Ossium Health)
CC-414
LD-01
BEY-4101C
CMPD-0431
Anti-CD19 CAR-T cell therapy(Bellicum Pharmaceuticals, Inc.)
CIGB-552
SNP-118
SNB-101
Autologous CD19/CD22 chimeric antigen receptor T-cell therapy(The University of Texas M.D. Anderson Cancer Center)
SynOV 1.2
Alpha-lactalbumin-oleic acid(Azanta A/S)
VB-10.16
Durlobactam/Sulbactam sodium
Bispecific antibodies(Go Therapeutics, Inc.)
BLNP-005
Anti-CD22 CAR T cell therapy(Bio-Raid)
JAB-A200
MPB-1734
ALM-201
Pro Ab (GlycoNex)
ATI-2231
Cyproterone Acetate/Ethinylestradiol
PRO-1135
Neoepitope yeast vaccine(Nantbioscience, Inc.)
PNK-CD16VP
TQB-2916
TARP peptide-pulsed autologous dendritic cell vaccine(National Cancer Institute)
GF-102
Alpha-tocopheroloxyacetic acid (Veana Therapeutics)
DEVA OV2
RTX-321
WM-P3
ML-107
AnDC-0001
AUT06NG
SH-3051
ROR1R-CAR
ALVAC-p53(Sanofi Pasteur SA)
IMT-073
AXT-301
BPI-2361
ETN-004
AR-23
Immune cell therapy (CoImmune/SCM Lifescience)
K562/GM-CSF vaccine
IN01
S-64315
KF-1602
SLC-391
IMP-10
CORT-122928
BP-1401
VRT-002-D
VRN-01
JS207
F16 IL2 fusion protein(Philogen SpA)
CD20 CAR-T cell therapy(Shanghai Longyao Biotech Co. Ltd.)
IPH-45
PN-3XX
AVA-6000
INO-9012/Human papillomavirus vaccine(University of Pennsylvania)
CLX ONC 164A2
BBT-012(Bolder BioTechnology, Inc.)
Distigmine Bromide
STC-1010
AR vaccine(Madison Vaccines, Inc.)
Prostate cancer vaccine(Onyvax Ltd.)
SAR-438859
BKT-300
P-28-R
68Ga-ICAM-1pep
GF-108
Anti-CTLA-4 and PD-1 CAR-T cell therapy(Shanghai Cell Therapy Group Co. Ltd.)
BR-2007
Tuvatexib
MB-102(Mustang Bio, Inc.)
ICP-113
SAL-0105
SG2901
Cintirorgon
VAR-102
GeniusVacMel4
Tribetarna
FT-573
68Ga-NODAGA-E[c(RGDyK)]2
Rivogenlecleucel
IACS-010759
BPI-9003
H3B-6545
Ad5-PTD-CgA-E1A-miR122
PVX-410
PTX-15
OMT-001
HLA-A1 MAGE-A4 (Adaptimmune)
BBT-931
Eritoran Tetrasodium
KD-225
BMS-986242
ASKC-852
PDS-0103
WSD-1227
SDV-1001
TRK-950
BG-129 nano liposomal
RP-110
CreaVax-RCC(JW CreaGene, Inc.)
MPL-5821
ADX-68692
HBM-9002
AR-035
XY0206
ICP-093
DCVAC/LuCa
Lutetium-177-PSMA-I&T
RP-17
HLA-A-0206 restricted URLC10 peptides
STACT TREX1
NMBS-1
PM-14
EP-0057
VT-02743
OPC-415
VIP-217
ES-018
AR-67
SB-11285
ABX-1431
AS-101
Interleukin 24 gene therapy(Multivir, Inc.)
Tendu Vaccine
Anti-CD19 and anti-CD22 CAR T cell therapy(Hebei Senlang Biotechnology Co. Ltd.)
ATX-201
MV-002
CU06-1004
EN-2001
SI-M016
SYB-010
NeoVAC DNA vaccine (Immunetune)
NR-19017
bacTRL E6/E7
BGS-2219
LOAd-713
GF-106
CISH inactivated TIL
REC-64151
INB-300
BITR-2101
CYT-01B
Anti-CD19/CD22 chimeric antigen receptor T cell therapy(Xi'an Jiaotong University)
Monosodium alpha luminol
ACB-1801
XL-265
KP-1406
UD-017
Ovarian cancer vaccine(Memorial Sloan-Kettering Cancer Center)
TILT-234
TRB-007
DI-Leu16-IL2
VG-204
CK-0807
HTL-002
BPI-23000
PH-894
SSC-002
VLV IL 12p35
PDS-0102
QL-1806
GSK-3039294
TQB-2868
LX-086
XTYW-002
UBI UPV 202
CNDO-109
Bimiralisib
Cancer vaccine(CanTech Canada)
TVI Melanoma 1
SIM-203-3
Virus like particle cancer vaccine (VLP Therapeutics)
SI-M017
VT-03003
KJ-01
Voruciclib Hydrochloride
IDP-312
Pd-1-pik
AMT-253
R-7016
Hemay107
Foslip
SI-001
ARN-6039
WXFL-1024H251
LYN-00203
IN-A003
GLIX-27
AVA-012
BI-3406
Deflexifol
AST-1001
VT-03029
ALD-R491
E-7766
NUC-7738
Dociparstat sodium
Apolipoprotein E(Centre Hospitalier Universitaire de Nimes)
Metarafenib
Site specific immunomodulators(Qu Biologics, Inc.)
RP-701(RESprotect GmbH)
CLXR-005
DF-008
[18F]Tetrafluoroborate
EPL-1410
Remetinostat
CVMG-01
DF-6000
Adva-27a
Crenigacestat
NIR-178
VY-201
Neoantigen peptide vaccine(Washington University School of Medicine)
Irisquinone
Dendritic cell-activated cytokine-induced killer cells (Shenzhen Hornetcorn Biotechnology)
IN-A013
Abrassin
WX-008
RP-0320
HS234
Pro-003
AU5-5
EO-2401
VIS-832
BMS-687681
Personalised cancer therapy ( BriaCell Therapeutics)
MX-402
OPD-5
CT-125A
AX-09
ENB-101
APH-0703
HS-10340
BEL-X-HG
Cyclin B1/WT-1/CEF peptide-loaded dendritic cell vaccine(Baylor Scott & White Research Institute (BSWRI))
SI-M006
RNA interference-based therapeutics(NuGenerex Immuno-Oncology, Inc.)
ThisCART7
SAR-445419
JAB-6000
IMA-201
RBN-012759
Allogeneic NK cell therapy (Alphageneron Pharmaceuticals)
PSC-100
MANA-512
ios H1
CLX-ONC-55A9
GEN2
Gamolenic acid
ITI-5000
BNT-115
DCVAC/OvCa
PXS-5382
siRNA-gemcitabine conjugate
ISA-201
VAR-101
STTG-014
EP-302
TQB-3473
YHC-1103
BCB-002
509
1ST-203
INO-9012
AST-081
APVO-437
Carcinoembryonic antigen-expressing measles virus(National Cancer Institute)
JAB-9000
VX-5
KD-275
DNP-004
L-asparaginase (Claris Lifesciences Ltd.)
ABSK-005
SYHA121-28
IO-130
DV-281
ID-11902
CPI-360
ITI-4000
AVD-701
RC-128
TBCV-91
IMU-201
DN-016
Amcasertib
C225-ILS-DOX
EPC-003
COF-001
BMS-986277
UB-VV200
CoTIL-01
LPX EWS/FL1 T2
AXT-501
LTX-401
Cenplacel-L (Celularity)
Quisinostat Hydrochloride
SH-2249
ONCR-177
AP-120
HMPL-002
NRC-2694
RR-001
Purine nucleoside phosphorylase gene therapy
INKmune
Vvax-001(ViciniVax BV)
CS-60001
Allogeneic EBV-specific anti-CD19 CAR-T cell therapy(Memorial Sloan-Kettering Cancer Center)
AVID-200
PP-008
DPM-1001
HCX-022
Ad-GMCAIX transduced dendritic cells
R-1004
LNA-i-miR-221
LY-3435151
CBX-15
BMS-833923
Enocitabine
HH-3241
OP-5244
COF-010
GENA-105
TERP API (Nanology Labs)
JRF-108
GEN-009
IB-002
BAT-1906
UCB-NK cell therapy (Shandong Golden Brick Biotechnology)
JAB-400
[131I]MIP-1095
JS013
NUV-569
KD-U60
BNT-121
GLB-2008
Tyroservaltide
TPX-02226
PEP-010
RP-2
CLL1-CD33 cCART cell therapy(iCell Gene Therapeutics, Inc.)
SHC-029
CD19-CART(Shanghai Unicar-Therapy Bio-medicine Technology Co. Ltd.)
DZ-1005
FID-010
ONM 400 Fab
ABD-3001
SPL-110
AGX-51
IMT-200
PD L1 dependent interferon alpha (Good Therapeutics)
JAB-3000
BMS-986310
YBL-010
AB-0531
NZ-TLR9
Altiratinib
NR-19021
RO-7122290
Eptaplatin
RVT-1601
Peptide-cocktail vaccine for hepatocellular carcinoma(OncoTherapy Science, Inc.)
Navoximod
Peptide pulsed dentritic cell vaccine(Kanazawa University)
MPI-2730
FHND-6091
ONM-500
VTP 600
BCN-303
recombinant candida utilis uricase(Beijing SL Pharmaceutical Co. Ltd.)
ART 838
ADEPT therapeutic(Cancer Research UK)
Neoantigen directed cancer vaccine (Transgene)
GL-ONC4
Alpha-Tocopheryloxyacetic acid
DCBCI-0901
SHS 001
OXS-1615
mRNA vaccine(eTheRNA immunotherapies NV)
YPN 005
CXD-101
GR-9059
ALT-801
JS211
GS-626510
BPI-004
NK-012
JM-100
NBT-558
FLAG-003
Renal cell carcinoma vaccine(Fbm-Pharma)
ZX-8000
DF-5001
PJ016
HP-163
STM-004
FROST-450
BCMA-CART(Shanghai Unicar-Therapy Bio-medicine Technology Co. Ltd.)
HM-87277
Solid tumour vaccine(Northwest Biotherapeutics, Inc.)
3-PO
SNP-175
SHEP-001
BCMA-CS1 cCAR T cell therapy(iCell Gene Therapeutics, Inc.)
Dezapelisib
XTX-201
AMT-116
BNC-105P
YTX-7739
AMG-319
ios H3
BPM-28740
ATLCAR.CD30 cells(Lineberger Comprehensive Cancer Center)
GS-4224
Angiocidin (Protheragen)
Sym-025
MVX-5005
KM-10544
CMG-017
BION-301
Dolcanatide
IMA-402
Small interfering RNA encapsulated nanocells(EnGeneIC Pty Ltd.)
VBI-2701
RP-4010
CGT-0206
KAND-145
BT-101094
ADV-300
ZG-001
PLX-7486
TP-235
IO-112
TPST-1495
T3P-Y058-739
WII-1906
AM-001
NK cell therapy (Shenzhen Hank Bioengineering Institute)
AU2-94
ITI-1001
BAY-2402234
MP-110
CD19 CAR-T(Huadao (Shanghai) Biomedical Co. Ltd.)
AST-05X
NK cell engager immunotherapeutic (Merck)
DN-019
DG-3173
VT-02875
LB-2
Sapitinib
HS-269
MBF-118
BCL-201
SNe-01
HyVax semi allogenic hybrid cell vaccines (SemiAlloGen)
GENA-104
JHU-083
CV-0903
PCUR-101
PUMVC3 DNA vaccine(University of Washington Bothell)
siRNA cancer therapeutics(Quark Pharmaceuticals, Inc.)
2 ,4-Dinitrochlorobenzene
CPO-107
PRT-811
Seviteronel
TLY-014
Anti-EGFR DART cell therapy (Sorrento Therapeutics)
PH 790 ACT NK Cell therapy Phio pharmaceuticals (Phio pharmaceuticals)
OBI-898
Navarixin
MORab-109
bi-shRNA-KRAS
ABL-404
ZS/DC P013 dendritic cell vaccine (Zhongsheng Kangyuan Biotechnology)
CEP-11981
LOXO-338
VT1093
MRTX-2219
Oncolytic virus cancer therapeutics(DNAtrix, Inc.)
ARX102
ABI-1968
IMP-08
Aminopterin
HTERT/survivin/CMV multipeptide vaccine(University of Pennsylvania)
HC-1102
ABSK-031
MOR-107
BNT-113
FNX-020
INO-5150
MDM2 degrader
Anti-CD22-CAR T cell therapy(Kecellitics Biotech Company Ltd)
EV-101
Saltikva
N-812
ONM-400-IL-2
L-ICON3
Trastuzumab amanitin antibody drug conjugate (Heidelberg Pharma AG)
Anti-CD33 CAR T cell therapy(Bio-Raid)
K-NK004
Encapsulated cell therapy (Rogosin Institute/Metromedia Bio-Science)
VT-02858
SYSA-1802
TriMixDC
MK-8353
CNC-225
MVA-EL
INXN-2001
Senl-002
ASTX-029
VX-25
AEOL-10150
PRO-1136
NY-ESO-1 peptide-pulsed autologous dendritic cell vaccine(National Cancer Institute)
SIM-1803-1A
MNPR-202
BTX-A51
CC-12507(Celgene Corp.)
CD22 CAR-T Cell Therapy(Hebei Senlang Biotechnology Co. Ltd.)
SCT-300
BPI-9220
GMI-1757
AG-636
PH 790-TME
ALM-301
ASKG-843
ABTL-0815
Minerval
TVI Brain 1
SLC-149
AVREV-02
Redaporfin
NBM-BMX softgel capsules
VTX-9911
SG-3-05021
ACTR 087/SEA BCMA combination therapy
Mipsagargin
TSC-203
Allogeneic G-NK cell therapy (Indapta Therapeutics/Stanford University/University of California San Francisco)
ATRS-1901
YH-siRNA2
Gestonorone Caproate
Anti-CD30 CAR-T cell therapy(National Cancer Institute)
PF-04929113
SY-003
KD-075
Hematoporphyrin Ether Ester
Anti-EGFR-IL-dox(Schweizerische Arbeitsgemeinschaft Für Klinische Krebsforschung)
RGT-A
CMG-04
PM-005
S-588210
ADX-1615
ET-1002
AMG-176
1ST-202
[18F]FLOR
ZL-2103
VT-01581
IN-B011
GEN-0101
MC3-LNP
SE-7552
Plasmodium immunotherapy for cancer (CAS Lamvac Biotech)
1928-zT-2(Chinese Academy of Sciences)
OBI-866
DAN-22
AG-B1622
GO-8H3
IVAC M uID
APO-010
RM-006
GM-101
EU-505
LPX EWS/FL1 T1
exoASO-STAT3
OMT-004
KD-033
ENB-301
SNP 7/8a
NZ-IO-003-004
G4-1
HLX-63
PYX-103
SYHA1807
LY-3410738
BNT-151
BR-2002
VT-02140
EN-1001
HB-001
Nocardia Rubra Cell Wall Skeleton for Injection(Fujian Shanhe Pharmaceutical Co Ltd)
MBF-132
RS-0139
INX-0001
CLX-ONC-55A6
TBCI-90
GLX-1
PENAO
SKY-02
3D-059
CPT-1550
SYHA-1817
RP-885(RESprotect GmbH)
GT-103
F-102
P-2002
VRN-09
Ad-IFN-alpha(The University of Texas System)
Allogenic gamma delta T cell therapy (Beijing GD Initiative Cell Therapy Technology)
TOP-V122
DW-167
QP-EN1
SPH1188-11
INTH-454
Edicotinib
CYL-02
HM-97211
Senl-005
BTM-3566
PSA/IL-2/GM-CSF vaccine (Oncbiomune Pharmaceuticals)
VT-04696
AU-101
LAP (mut) IL-2 T peptide (Stealthyx Therapeutics)
MS-1601A
PAC-1
HSB-888
Low Molecular Ganoderma Lucidum Polysaccharide
TJC4-CK
OTSA 101 DTPA-111In
MI-180021
XH-30002
PRX-034
SLSP-05
CV-9202
Hydroxytyrosol
PF-06939999
HS-201
ZB-520
Sulfamide-nitroimidazole
BAT-7102
NR-19020
JAB-25000
Proliposomal intravesical paclitaxel
Paclitaxel/Ritonavir
Hemay060
YH-BIO7
TKD activated NK cells (Alphageneron Pharmaceuticals)
SVV-044
IMSA-101
VTX-1849
ADCV-01
ABSK-003
JBI-1527
CYAD-02
DIACC-2010
GL-23X
Vx-006
PF-06855800
TC-310
XNW-1031
IMT-07
MK-7162
Octreotide(Peptron, Inc.)
CYT-001
SHC 020
131I-PSMA-1095
Avadomide
ALRN-6924
Autologous dendritic cell immunotherapy (APAC Biotech)
AMG-553
NCB-002
MANA-312
VXM-08
TVGV-1
iNeo-Vac-P01
LEM-S403
ios H2
bacTRL OV
HiDCV-OS1
ABL-202
NHM-CT-007
Dendritic cell product(TriMed Biotech, Inc.)
CEP-9722
SNA-07
SDT-101马来酸盐
Tarloxotinib Bromide
MTX-241
PDMX-1001
rMVA-CD40L
Ziv-aflibercept biosimiliar(Shandong Boan Biological Technology Co. Ltd.)
PZH-2111
IST-4
ChAdOx1 MVA 5T4 vaccine (Vaccitech)
SNP-119
XNTR-938
AZD-0171
KFP-H018
MW-05
CIM-101
IN-04
NKG2C/IL-15/CD33 TriKE (GT Biopharma)
ICP-790
NBF-006
AVA-014
ID-11912
MANA-412
Rocilinostat
Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein(Fred Hutchinson Cancer Research Center)
BMS-986301
BGS-2019
DN-020
WPD-102
CZ-48
VLX-600
Ifetroban
Carboxyamidotriazole
TVI Prostate 1
ATA-2431
LP-400
YZJ-0673 Maleate
YH-BIO6
HL-5101
CLX-ONC-55A3
NKTR-262
CMB-305
VRP-007
KRM-20
SNB-102
OMO-103
BPI-27336
BPI-9120
HM-81442
Indotecan
Mivebresib
PRO-1107
MDX-124
GLPG-0187
GLIX-23
Anti-PSMA CAR T-cell therapy(Sorrento Therapeutics, Inc.)
ENO-5001
CRB-602
DFP-13318
Hepatitis B vaccine(GlaxoSmithKline Plc)
BPI-003
ALMB-0168
Prednimustine
IN-B008
OMT-114
NLG802
Anti-BCMA anti-CD38 bispecific chimeric antigen receptor T cell therapy(Shengyan Pharmaceutical Technology)
BI-831266
STA-9183
BPI-16000
ARV-1802
NED-170
ENV-0205
Rabeprazole Sodium/Clarithromycin/Amoxicillin
CYT-6091
RB-340
PerCellVac2
Citarinostat
Oxy-210
BI-1910
MAX-4-A
AK-321
VET4-H1
CTX-030916
RG-7741
HLX-09
ENB-005
Jade (Cullinan Oncology/Fred Hutchinson Cancer Research Center)
QBKPN-SSI
APL 108
JNJ-2641585
DC-Vac/EP-L(BINEX Co. Ltd.)
OB-002H
OTS-167
3D-057
Disomotide
RPT GCN2i
TVI Kidney 1
Alhena Project
GSK-1795091
ETN-007
Long Peptide Vaccine LPV7
XBH-25
TOL-1
FID-007C
HMPL-306
EG-i21
GALE-302
Antigen p64K hVEGFKDR adjuvant NAcGM3 VSSP
Amphiphile RNAi therapeutics(Elicio Therapeutics, Inc.)
HH-2710
CAR-T cell therapy (Shenzhen Inno Immunization)
Motolimod
CSC-012-ADC
MPD-002
CBX-16
SPH-3261
OPS-2
HuOHX10
SAUG-1
TT-014
ORP-005(ORPHELIA Pharma SA)
C1 Esterase Inhibitor (Human) (ViroPharma)
VB-6008(Viventia Biotech, Inc.)
HTL-001
SYO-1644
CIM-102
DCC-3116
Rexlemestrocel L (Mesoblast/Teva Pharmaceutical Industries)
VG-203
2X-121
WM-P5
FF-10501
S-81694
MG1-HPV
TT-004
YHO-1701
XBH-41
TYG-100
WTS-004
AUTO2-NG
VRT-002-P
RTX-003
TRPH-395
PM-003
PRGN-2009
CSF-470
TTC-352
CD19 CARvac T cell therapy(iCell Gene Therapeutics, Inc.)
CD19 UCAR-T cell therapy(Shanghai Longyao Biotech Co. Ltd.)
TTX-334
Recombinant cytokine gene derived protein(Genova, Inc.)
FC-116
AZ-6197
JAB-BX100
HP505
AUC-029
ETN-002
EP-2101
HC-X025
SHC-025
DPX SurMAGE
RD-128
STW-284
HLA-A-0201 restricted URLC10 peptides
IFx-Hu2.0
TMC-Ag5
SL-1001
Tarenflurbil
CYT-1853
NeoCura IM-001
SGN-1
YH NCE8
AntiCEA DART Cell Therapy (Sorrento Therapeutics)
BJY-810
PXS-5338
Dutogliptin Tartrate
BI-9811
FLAG-094
FluBHPVE6E7
Phortress
SB-1703
Gandotinib
CRC-03
DNA vaccine(Belarusian Research Center For Pediatric Oncology, Hematology And Immunology)
DNP-002
HBW-3090
EPC-004
CSR02-Fab-TF
CLX-155
ADG-153
LY01010
VEGFR-1/2 peptide vaccine(Keio University)
SSC-001
Belotecan Hydrochloride
Bifikafusp alfa
CV6-168
RXDX-106
CTA-301
YHC-2120
X-4136
HM-97662
BPI-8001
APG-157
PTX-35
HSB-720
WBC100
NT-1195
APN-421
VLX-1570
MG-7-DC vaccine
Valo-C1
CCX-872
Anti-CD19 CAR T-cell therapy(Leidos Holdings, Inc.)
M-4645
IM-059
DH-001
Anti-CD123 CAR T cell therapy(Shanghai Genechem Co. Ltd.)
APL-801
HMPL-295S1
Sym-026
INA-03
OVV-01
IDH1 peptide vaccine(Deutsches Krebsforschungszentrum, Dkfz)
AZ-4374
Autologous genetically modified ADPA2M4CD8 cells (Adaptimmune)
Anti-MUC1 CAR T cell(Guangzhou Anjie Biomedical Technology Co. Ltd.)
HGP-1302
ASLAN-002
OT-1096
B-5626
bacTRL CD3
Tergenpumatucel-L
PD-1 targeted T cell
sd-rxRNA based therapeutics
CB-668
BLU-2069
BBI-801
XTX-401
V 01 (HangZhou ConVerd)
TQBWX-220
AXT-201
MB-104
AU-409
BMS-911543
3E10-D31N
OSX-001
TQB-3728
NTX-301
GO-4C8
EGEN-002
PN-201
LVGN-3616
R-OKY-034F
DFF-332
KH-903(Chengdu Kanghong Biotechnology Co. Ltd.)
BI-905677
LYN-00205
ENO-4002
TZ-102
CLR-2100 (Cellectar Biosciences/Onconova Therapeutics)
1RG-CART
ABL-506
DDC-3
Osteodex
IL-12 gene therapy(The Methodist Hospitals, Inc.)
aCD19z
HX-301
RTX-IL-12
Spebrutinib
GS-3583
TVI Ovary 1
MG1MA3
HTERT vaccine multi-peptide vaccine(University of Pennsylvania)
OKI-422
JAB-7000
NPT520-337
ALEXIS AIDT-2 EOC
JNJ-8120
YH-24931
Surv.m-CRA-1
AMXI-2001
Senexin B
ICG-136
BXCL-702
SI-M023
ES-012
TT-015
JNJ-74856665
BVAC C
HLX-54
COH-29
HBW-3070
BPI-9320
JM-200
AFX-9901
IMA-204
4SCAR-GD2(Zhujiang Hospital of Southern Medical University)
PRS-344
BJY-806
ES-015
PD-1 knockout engineered T cells(West China Hospital)
Cervical cancer vaccine(Immunitor, Inc.)
PM-004
Human papillomavirus vaccine TA-CIN(Xenova Ltd.)
Anti-CD19-CAR T cell therapy(Kecellitics Biotech Company Ltd)
KSQ-427
NCE-001
RG-001
AVA-04-VbP
K-NK00X
Neoantigen Dendritic Cell Vaccine（Bristol-Myers Squibb）
Recombinant coxsackievirus B3
TAEK-VAC-HerBy
V3-MOMMO
ADXS-503
EU-101
IAG-933
L2-P4
TAS-1440
AZD-8797
pbi-shRNA STMN1 Lipoplex
KD-299
CIGB-300
SLSP-04
XNTR-955
ALG-070017
DDC-4
YH-NCE7
CD40L-GVAX
RP-216
IO-120
STW-324
Anti-BCMA DART cell therapy (Sorrento Therapeutics)
PRS-010(Pieris Pharmaceuticals, Inc.)
SPLS-1
PD-1 knockout engineered T cells(Anhui Korton Biological Technology Co Ltd)
DFP-14927
MG-4101
KD-U225
SC-005
Senl-1904A
MBS-8
VB-6901(Viventia Biotech, Inc.)
Tuberculosis vaccine(Archivel Farma SL)
AMXI-3001
Pinometostat
RG-6146
Boanmycin hydrochloride
HB-201
VT CMV
rRp450
HBM-7018
KD-323
BLU-852
Hematoporphyrin
Foslinanib(Xingtai Ruizhuang Biotechnology Co Ltd)
DPX BRAF/CPA
YZJ-2440
HSP Gp96 vaccine (Cure and Sure Biotech)
HER2 cancer vaccine(Pevion Biotech AG)
GTA-105
V3 OVA(Immunitor, Inc.)
ALG-070043
Anti-CD19 CAR T-cell therapy(Dongguan People's Hospital)
BLA1-M002A
EC-359
Opal (Cullinan Oncology)
(9Z)-UAB-30
TQB-3303
DN-024
Hamlet complexes(Azanta A/S)
AB-062
BI-891065
GLS-5140
ID-61901
QS-21
PANDA-VAC
Peplomycin Sulfate
SYB-509
sEphB4-HAS
STI-2798
CPG-10104
Fosfomycin Sodium
WIF-2001
SSC-003
WFT-2
HH-18202
MU-D201
ARX-822
CWP-232291
KY1701
BAT-6004
DN-015
APN-401
KD-GT015
Phorbol 12-myristate 13-acetate
TMC Ag3
CPL-410-005
ASC-06
QUILT 3.080
SC-43
VB-6050(Viventia Biotech, Inc.)
Arglabin
ATT-11T
CTL-119
OMTX-703
Calphostins
ONCOS-210
GLYCAR T cell therapy(Baylor College of Medicine)
SHR-2150
SHC-026
Recombinant alpha-tumor necrosis factor-thymosin-alpha-1(Pharmaclon)
SD-133
Fosgel
VB-6011(Viventia Biotech, Inc.)
VRN-08
Tyroserleutide
QBECP (Qu Biologics)
Oncolytic measles virus encoding thyroidal sodium iodide symporter(Vyriad, Inc.)
VT-1092
GND-007
LY-01019
Anti-CD20 CAR T-cell therapy(Shanghai Longyao Biotech Co. Ltd.)
ATL-1102
ABREV-01
IO-102
Hemay030
AB-610
MAX-2
APL-612
GNS-1653
YH-BIO5
Neostigmine Bromide
MCY-C55
T-1201
Debio 4028
YHC-2119
XZP-3621-1001
CM-316
UBI UPV 201
CRN-01941
TAX-2
Telapristone Acetate
AutoSynVax vaccine (Agenus/PureMHC)
CORT-125281
KAND-757
VB10.NEO
Autologous anti-NY-ESO1 T-cell receptor gene-engineered peripheral blood lymphocytes(Roswell Park Comprehensive Cancer Center)
GNC-T04
QBSAU (Qu Biologics)
JAB-24000
SPH-4336
VT-02264
HPN-C01
V-myoma(Immunitor, Inc.)
ITI-7000
BLNP-006
HRS-8080
BPI-8002
SRX-3254
TGFBeta-resistant-HER2-EBV-CTLs
SHC-034
MBS-2320
PPMX-T003
Asparaginase erythrocyte encapsulated(ERYTech Pharma SA)
SIM-325
LYN-00201
Harringtonine
BRM-011
AT-7519
NLM-001
Wilms' tumor gene peptide vaccine(Osaka University)
MSI-vaccine
KNP 502
GL-233
NR-19018
CH-5183284
ALEXIS AIDT-2 MPM
FID-007G
NY-ESO-1-specific TIM biologic (Tavotek Biotherapeutics)
SX-682
BPI-9007
Nanocurcumin(Tehran University of Medical Sciences)
Vx-001
BLNP-004
TXR-311
PRO-1109
COF-007
E-7130
VT-02043
AVA-018
CD30 CAR-T cell therapy(Tessa Therapeutics Pte Ltd.)
WT-4869
Dexamethasone/Netilmicin Sulfate
DCB-CA1
VRN-06
MDNA-19
Group A streptococci, attenuated(Wuhan Institute of Biological Products Co. Ltd.)
Therapeutic DNA vaccines(Vaccibody AS)
XP-103
B7-2/GM-CSF cancer gene therapy
IVT-8086
BTX-1050
BCD-115
High-affinity CD16-expressing NK cell therapy (ImmunityBio)
Anti-CD19 CAR-T cell therapy(Shenzhen Geno-Immune Medical Institute)
HLA-A24 MAGE-A4 (Adaptimmune)
DPV-008
CD25 x CTLA-4 bispecific DART molecule (MacroGenics)
IN-B005
HY-010
SNB-301
FIT-101
TPST-8844
SPX-1009
Allitinib Tosylate
OMT-002
LPM-3480226
SRX-3225
Bicyclol
BGS-2223
Mefatinib
PFK-158
BG-129
Ovarian cancer vaccine(Northwest Biotherapeutics, Inc.)
ATP-128
E-7386
QBS-10072S
CAP-100
TVI Leukaemia 1
M-7583
CPL-304110
OV FV 01
XBH-40
BNC-1251
UniCAR02-T-pPSMA
ABBV-467
Se-Methylselenocysteine
ABL-203
FT-6876
ANP-016
PRIM-DJ2727
hTERT peptide-based vaccine(Invectys SA)
NX-9
BR-2008
VB-7756(Viventia Biotech, Inc.)
HSK-26784
K-1
Dilanubicel (Nohla Therapeutics)
GB-801
Neoepitope-based immunotherapies(Advaxis, Inc.)
NUV-1182
ZK-011
Anti-CD19 CAR T-cell therapy(Sheba Medical Center)
Cytosine deaminase herpes simplex virus-1/thymidine kinase fusion gene therapy
MVC-101
ZI-H04
1ST-204
BAY-1830839
AZD-4320
Lobaplatin
JPX-1188
TAS-3681
LB-201
TT-ROMI
DNP-005
FNX-006
GL-2B2
NMBS-2
ST-2286
ADXS-504
ML-111
Molibresib
ONCR-GBM
SNX-631
Triptolide
Epertinib
BAY-218
GDX-012
BKC-1502A
NU-0129
WX-047
MET DecAb
WU-NK-101
ENB-004
VT-02758
AVD-601
ABBV-623
WM-S2
XAGE-1 derived peptide vaccine(Kawasaki Medical School)
SPK-241
B010-A
GPC-3298306
Gallium-68 NOTA AE105(Curasight A/S)
AG 02 saporin conjugate
CD123 CAR-T cells(Hebei Senlang Biotechnology Co. Ltd.)
LGK-974
BLNP-020
HGP-1423
MTR-116
KNP-102
IMT-400
MAX-5
IN-A005
DT-095895
TC-410
ERAS-3537
ONCR-153
UBI VLP 301
PEPA-10
DUET-02
PRO-1173
agenT 04002
PGG-Glucan (Alpha-Beta Technology, Inc.)
SM-04755
Fosfestrol Sodium
Kappa-CD28-T-cells
CP-506
BPI-9011
OC-604
ABSK-004
Entinote (EOC Pharma)
VMD-928
Allogenic gamma delta T cells therapy (Beroni Group)
Polyclonal antibody stimulator(Aphton Corp.)
TK-1112
RASP-201
RO7283420
TLD-1433
HLX-24
FIT-039
TWP-102
ios H5
DN-018
ONCR NEP
ABSK-013
APL-601
Tumour lysate particle loaded dendritic cell vaccine
JNJ-67544412
SNA-01
MDK-271
AVA-027
PNQ-103-1
CS-27100
VER-250840
KFP-H013
EGFR t-haNK (ImmunityBio)
AK-423
TNBC vaccine(BioNTech SE)
EPI-N06
CPT-60621
MCI-048
Telomerase peptide cancer vaccine(Genovax SRL)
DDC-1
DAC-0060
KD-010
TMX-202
BCG for therapeutic use
Ursolic Acid
Pegarginase(Bio-Cancer Treatment International Ltd.)
MEDI-9090
SL-901
PTX-101
Pro-001
SynOV 1.3
SEL-110
Recombinant Human Ad-p53
HRS-7415
Al18F-NOTA-octreotide
WII-2001
TT-18
AGM-130
V3-Myoma
BCI-1124
Starvanip
TRK-880
PF-06873600
ML-815
HER2/neu peptide vaccine(University of Washington Medical Center)
HDT-201
KD-060
SOL-686
IO-140
SXL-01
LMY-232
Tumor lysate particle only vaccine (Orbis Health Solutions)
TCB-004
SHC-019
IMC-J110C
304 (3SBio)
KHK-2455
SOL-578
TT-701
SNA-02
KYAN-001
SAL-0106
99mTc-RWY
DBPR-114
PSMA XPAT
AB-110
Peptide loaded dendritic cell vaccine(National Cancer Institute)
TAS-0313
VB10-NEO(Vaccibody AS)
Omtriptolide sodium
ICP-B03
GENA-104A07
AZD-3458
IVAC W bre1 uID(BioNTech SE)
Compound 451238
UM-EEDi-5285
TK-0118
ENMD-2076
AT-1511
LYN-00301
GSK-6097608
J2H-1908
KJ-02
ABL-204
KNP-101
PNQ-201
CD16-IL15-CLEC12A TriKE
TQB-3617
Anti-CD30 chimeric antigen receptor T cell therapy(Immune Cell Therapy, Inc.)
APX-701
VET3-NK
AUS-131
GSK-2302032A
IB-003
RG-7775
KAN-0440550
Hydroquinone
BPI-19000
COG-112
XNW-1026
HEC-73543
CC-96673
YH-BIO8
anti-GPRC5D CAR T-cell therapy ( Bristol Myers Squibble)
KZR TBD
AT-1636
ZG-006
TR-57
NG-2001
ANP-014
GNOS-PV02
Selitrectinib
Cancer vaccine (PhotonPharma)
Paclitaxtide
BPI-2241
RP-656(RESprotect GmbH)
STTG-005
DFP-17729
L-asparaginase (Chandra Bhagat Pharma Ltd.)
HS-10381
BAY-1161116
ICP-008
Anti-CD7 CARcell therapy (iCell Gene Therapeutics)
LY-3214996
Celyvir
HLA-A24 AFP (Adaptimmune)
JAB-100
Nutraquinol
SON-2014
NJB-834
Costimulatory bispecific (Janux Therapeutics)
RGT-587
VSV-hIFNbeta-NIS(The University of Tennessee at Martin)
SG-3-05429
KP-0832
VT-01558
TAS-05567
BST-204
FK-PC101
AV001(Adaptvac ApS)
GL-238
CS-53001
Canerpaturev(University of Utah)
PH 762-ACT
GNC-T02
Amina-X
CC-95266
BCG Live(Organon & Co.)
Sodium Demethylcantharidate
BACPTDP
SHS-003
NBT-578
GP2 peptide vaccine(Cancer Insight LLC)
OR-070
Anti-CD30 CAR T-cell therapy(Bio-Raid)
Tax peptide-pulsed dendritic cell vaccine
NEXI-001
ARV-1502
Compound aluminum sulfate
Crolibulin
ARC-100
GM-1485
Silicon phthalocyanine 4
EPI-068
RASP-301
Serabelisib
SIM-203-1
APL-581
CC-92328
OT-82
Personalized peptide vaccine(Kurume University)
RGT-B
KO-2806
CLR-2000045
ONCR-148
Alpha 4CB 1.1
WM-P2
DN-021
Drug discovery(PCI Biotech Holding ASA)
ZS/DC P014 dendritic cell vaccine (Zhongsheng Kangyuan Biotechnology)
Salutaxel
Monepantel
OPDC 3
Modi 2
Anti-CD19 CAR T-cell therapy(Nanjing CART Medical Technologies Co. Ltd.)
Alpha 4CB 2
CS-3005
AL-58922
H-31970-SAGAN
Hu8H9 (Y-mAbs Therapeutics)
PD-1 knockout engineered T cells(CELL BIOTECH Co. Ltd.)
LY-3415244
JS101
CYT-0851
ACP-0052
Vigil HCC ( Gradalis)
ZHB-202
IM-176
Transforming growth factor beta blocker (Good Therapeutics)
TVI Breast 1
NMIL-12-1
GDC-0570
Vigil ST ( Gradalis)
MDNA-413
BIL-022c
AZ-304
AUTO 7
AE-M
TK-1412
DVX-201
BI-765049
BAY-2701438
ZS/DC P012 dendritic cell vaccine (Zhongsheng Kangyuan Biotechnology)
BT-7455
OMT-003
Kite-037
GSK-2256098
Tenalisib
URLC10/CDCA1/KOC1 derived peptide vaccine(The University of Tokyo Hospital)
Multipeptide vaccine(German Consortium For Translational Cancer Research)
VRT-002-G
BP-011
AVA-017
TP-1454
Sarcoma vaccine(Memorial Sloan-Kettering Cancer Center)
TSC-202
Quercetin
CM-328
APN-431
PM-002
XBH-54
Autologous cancer vaccine(Regeneus Ltd.)
KYN-175
N-Glycolyl GM3 cancer vaccine (Center of Molecular Immunology/Recombio)
PEG-L-asparaginase(Dmitry Rogachev Federal Research And Clinical Centre Of Paediatric Haematology, Oncology And Immunology)
SPH-6516
CNC-118
Valproic Acid/Prednisone
XNTR-924
PP-004
MQ-710
APR-003
ABBV-CLS-579
C-0021158
Enhanced interlekin 18 therapeutic (Bright Peak Therapeutics)
T-cell receptor gene therapy (Precigen Inc/ZIOPHARM Oncology)
M-6123
NSC-631570
E39+GM-CSF vaccine
LY-3475070
Senl-007
Vigil CRC ( Gradalis)
Hepcortespenlisimut-L
MP-0274
IMC-nyeso(Immunocore Ltd.)
Tetrahydrouridine
Hu-7691
BAY-2476568
Roxatidine Acetate Hydrochloride
177Lu-DOTA-ABM
MDC-2050
VT-WT1
BPI-24000
BBI-3000
SC-0011
STTG-004
Oxysterols(Centre National de la Recherche Scientifique)
Zibotentan
XNTR-956
ID-11913
SH-748
IBI-102
ARQ-761
XNTR-936
CAL-056 mesylate
GT-1620
VT Tri allogeneic cell therapy (ViGenCell)
CBT-103
VT EBV
Pro-004
TG-6010
AV-MEL-1
ORX-101
YH-NCE4
Polyepitope DNA vaccine(Washington University School of Medicine)
Anti-CEA CAR T cell therapy(Shanghai Genechem Co. Ltd.)
SH-1896
MS-533
EPC 002
TL-938
GO-2032c
Endovion
INV-441
Valecobulin
AT-13148
188Re-SSS Lipiodol
L-DOS-47
TP-2846
Tumour peptide-pulsed dendritic cell vaccine (Tella)
ZG-170607
Disitertide
XNW-2012
GLG-801
DZ-1003
LQ-001
SK-NBP615
BPI-002
SAUG 2
TALL-104
MCI-062
DTT-304
IGF-drug conjugates(IGF Oncology LLC)
RT-AR001
WFT-1
Multipeptide-based immunotherapy(German Consortium For Translational Cancer Research)
BPI-20000
CPI-482
ON-108600
JAB-8000
DWJ-816S002
BCN-112
PAN-90806
ZS/DC P010 dendritic cell vaccine (Zhongsheng Kangyuan Biotechnology)
TC-220
INO-5151
ERAS-3788
CIGB-228
Andes-1537
PLX-2853
ION-929
PH-3861
OXU-004
Asparaginase (Pharmedic Laboratories Pvt Ltd.)
HLX-59
MAX-4-S
Recombinant human endostatin adenovirus(Chengdu Enduoshi Biological Engineering Technology Co Ltd)
OST-499
AKR-302
Anti-CD22 CAR-T cell therapy(Aikangd Biomedical Technology (Suzhou) Co Ltd)
CBLB-612
Parvovirus H-1(Oryx Gmbh & Co)
IPP-204106
Plocabulin
Hyperpolarized C13 pyruvate
SVV 024
S-488210
SUN-131(Senju Pharmaceutical Co. Ltd.)
CART22-cells
JNJ-75276617
SH-3809
VT Tri autologuos cell therapy
ITX-401
CU-05
Anti-CD19 CAR-T therapy(The First People'S Hospital Of Yuhang District)
WXWH-0240
ONM-401
Dendritic cell survivin vaccine(H. Lee Moffitt Cancer Center & Research Institute, Inc.)
ABL-403
TAS-114
NK cell therapy (CellProtect Nordic Pharmaceuticals)
HLCN-061
PMR-116
Neoepitope immunotherapy(Immunovaccine Technologies, Inc.)
ADC-129
SFA-005
IPR-1110
IO-101
Oncoimmunome
Mammaglobin A DNA vaccine
Tomivosertib
IN-02
IMA-301
ATL-001
AVA-006
YHC-2124
K-975
HBW-6000
Recombinant human adenovirus type 5
BPI-21668
IS-001
AU-105
DFP-11207
MicroRNA encapsulated nanocells (EnGeneIC)
VAX-014
Pro-002
ID-11909
OMT-113
MBF-362
KSP-QRH-E3-IRDye800
SHEP-002
AVX-901(AlphaVax, Inc.)
EPIM-002
JAB-26000
Tumour infiltrating lymphocytes (Iovance Biotherapeutics)
BMS-813160
Anti-CD22 CAR T cell therapy(Shanghai Genechem Co. Ltd.)
BLNP-012
YHC-2122
BDTX-700
Stem cell grafts (Miltenyi Biotech)
Senl-006
TAK-676
HER2 t-haNK (ImmunityBio)
PAP Vaccine(Madison Vaccines, Inc.)
Mivotilate
SVX-1
SKY-01
PP-006
ENA-002
HM-97594
TT-005
Rexin-G
YHC-1128
Melanoma vaccine(AVAX Technologies, Inc.)
GNOS PV01 + INO 9012
OB-003
TYME-18
Anti-CD20 DART cell therapy (Sorrento Therapeutics)
DPV-007
JS-011
ABC-131
Anti-CD33 chimeric antigen receptor T cell therapy(ZIOPHARM Oncology, Inc.)
PT-157
LH-1802
PT-2385
CYTO-T-101
CU-04
MIT-002
SNA-03
LOP-001
GSK-3368715
NEOS-518
4R9 - GC Pharma
BO-112
WT-35021
IN-A007
STTG-003
K-NK-003
Ladarixin Sodium
IPH-65
Anti-CD19 chimeric antigen receptor T cell therapy (Takara Bio)
BBP-454
BLA1-M005A
XBH-37
SVV-058
Individualised cancer vaccine (Immunovative Therapies)
CBL-0137
AVD-401
Anti-EGFR CAR-T cell therapy(Cellular Biomedicine Group, Inc.)
Balixafortide
NCE-401
DPV-009
STTG-011
CEP-37440
MVT-602
SJP-1602
JAB-4000
HSV-1G207
Anti-CD19 CAR-T cell therapy(Shandong Sinobioway Biomedicine Co. Ltd.)
CPI-182
HRS-2398
Arsenious Acid
KAZ-954
IMT-504
Neoantigen Dendritic Cell Vaccine (Bristol-Myers Squibb)
AC0078
IN-03
DF-003
TVI Colon 1
Dalantercept
OST-122
KTX-582
PNQ-370
ITI-2000
ABBV-637
RC-58
JAB-BX200
BB-401
Anti-CD19 CAR T cell therapy(Shanghai Genechem Co. Ltd.)
RNA CART-cMET(University of Pennsylvania)
Pentamycin
RC-68
Oncolytic viruses(EpicentRx, Inc.)
AWAKE LM PV
ID-11911
PXS-LOXi
TAK-243
COMPOUND 2055269
pGBI-140
SM-09419
Anti-CD19 CAR T cell therapy(Bio-Raid)
BLNP-017
JCAR-023
Felezonexor
SV BR 1 GM cancer vaccine ( BriaCell Therapeutics)
DFN-529
IPI-549
STTG-009
HZ-H08905
Dasatinib nanoparticle formulation(Xspray Pharma AB)
IDP-233
CLL-1.CAR T cell therapy(Baylor College of Medicine)
Golotimod
JRF 106
STW-264
LEM-S405
ABX-196
KD-207
Avasopasem manganese
GDX-023
COF-009
CFI-402257
DNAJB1-PRKACA peptide vaccine
Nedisertib
SHR-5126
OPL-0101
DEVA-OV1
IDP-601
CC-96191
CBX-1
HEC-89736
JAB 300
BT-001
NY-ESO-1 antigen-specific TCR-gene-transduced autologous lymphocytes(Takara Bio Inc.)
TP-1287
DWJ-816S001
BPI-9008
vinflunine
CS-2004
Anti-GD2 DART cell therapy (Sorrento Therapeutics)
CD19-CAR
APN-411
STB-C017
ADXS-506
Anti-CD19 and anti-CD20 CAR-T cell therapy(The Medical College of Wisconsin, Inc.)
PRECIOUS-01
KRM-19
3rd-gen-CD19-CAR
APC-100
IMT-19
LY-2874455
BLNP-011
MicroSoy-20
121564
BAT-6019
TOL-2
SGT-53
Anti-CD123 DART cell therapy (Sorrento Therapeutics)
Inavolisib
KINE-401
ALT-702
DH-348
Xanthohumol
ICT19G1
BPI-2021
CNC 332
Oxy-186
MAGE-A10-specific TIM biologic (Tavotek Biotherapeutics)
BLI-1301
AC0002
6-Gingerol
AUM-003
GSK-3745417
ENL-210(Enlyton Ltd.)
Anti-CD123 chimeric antigen receptor T cell therapy(Chongqing Precision Biotechnology Co. Ltd.)
C7R-GD2.CART cell therapy(Baylor College of Medicine)
Vax NK/HCC
SCB-01A
ASN-001
Excindogen (Vitalgenics)
Amoxicillin/Metronidazole/Vonoprazan Fumarate
TQB-3454
bacTRL Fc
EP-201
TAS-117
18F-αvβ6-Binding-Peptide
VT-02011
ZSP-1602
ATH-055
Glioblastoma DNA vaccine(Vical, Inc.)
2-Hydroxyflutamide
SOR-C13
HC-X030
PQR-401
PDS-0104
PIN-2
CreaVax-BC
R-1025
Oshadi R
RO-7119929
CKD-509
Onalespib
FLAG-001
SIM-200
Tractinostat
SVV-037
Cancer vaccine(Pan American Cancer Treatment Center)
LC autologous blood origin T lymphocyte
METI-101
SL-V60
Prostate cancer subunit vaccine (Progenics)
SKL-27969
SNe-02
YH-25248
ORX-102
TMV-018
AZD-2811
CT-732
MSX-122
HSV-1716
AST-003
GNC-T01
INI-2004
Fms-like tyrosine kinase 3 ligand(Amgen, Inc.)
GRN-1201
Mycobacterium cell wall-DNA Complex(Liminal BioSciences, Inc.)
Elomotecan Hydrochloride
CS-3004
ETN-005
HLX-51
OSX-002
SPYK-04
TG-4050
BLU-6348
HG-3001
PG-545
SIM-236
Personalised LADD immunotherapy (Chinook Therapeutics)
D-0751
ISR-50
HP-510
Dopastatin
IN-B007
Glycididazole Sodium
PM-3002
IL6 Deleted CD19-CART (Shanghai Unicar-Therapy Bio-medicine Technology Co. Ltd.)
SHS-007
LBP-1
R-7009
Peptide-pulsed autologous dendritic cell vaccine(Radboud University Nijmegen)
LCAR-M23
OLX-801A
ES2B-C001
Fosifloxuridine nafalbenamide(Cardiff University)
AU4-53
TSC 102
Keynatinib (Medolution)
CUE-103
HLX-25
STW-292
GSK-2879552
APL-901
ND-2110
VT-02123
Domatinostat tosylate
IDH1R132H peptide vaccine(Deutsches Krebsforschungszentrum, Dkfz)
KAN-0439834
Colorectal cancer DNA vaccine(Karolinska Institutet)
LEM-S404
BNC-1501
sig-HELP-E6SH-kdel
PBF-999
MAM-A DNA vaccine(Washington University in St. Louis)
OR-1701
BLNP-025
OPB-171775
NBE-105
WTS-005
ACP-2127
GTB-4550
Alofanib
ARN-7016
IL13Ralpha2 CAR-T cell therapy(University of California)
4-peptide melanoma vaccine(Eisai Co. Ltd.)
Anti-EGFRvIII-CAR
ICP-636
MPI-2720
ONO-4578
PB-103
IS-002
HGP-1478
CPI-200
STC XXXX
VAC-1
VOB-560
AT-1965
CS-17938
ID-11918
BN-201
AGI-134
CYC-800
ABN-401
Lipovaxin-MM
ATA-2321
OKY-034
BSG-001
Anti-thyroid stimulating hormone receptor chimeric antigen receptor T cell therapy(Innovative Cellular Therapeutics Co. Ltd.)
Tefinostat
CK1 alpha degrader
ERAS-3599
ENOB-DC-11
NG-769A
NSC-281612
HC-X30
Fadrozole monohydrochloride
PRO-1103
ETN-006
HJ-N-001
AFX-1251
MDK-202
TVI Lung 1
BMC-128
DDC-2
Gene edited antibody resistant NK cell therapy (Coeptis Pharmaceuticals)
Selurampanel
BT-1053
MBF-015
WP-1732
HC-X021
CPI-893
BJ-004
IMD-110
Fisogatinib
BLNP-007
BCY-11864
MDNA-109FA-Fc
BLNP-009
TTI-10001
Enadenotucirev
BLU-222
MV-209
INCB-59872
ETN-003
MK-2206
Losoxantrone hydrochloride
B-cell based antigen vaccine (Femtobiomed)
LUNAR-101
CLBR-001/SWI-019
SI-M024
ASTX-660
GO-17A3
MPI-2710
ENB-201
FLX-475
CPI-169
ADI-002
WHSC2-103 peptide vaccine(Kurume University)
MC-30
VG-202
VTX-1225
TQB3562
EN-3001
ESK-1
ITI-6000
DPV-002
ASTX-295
SOT201
VTP-850
CC-95775
Peptide-based cancer vaccine(OncoTherapy Science, Inc.)
OMN-54
SF-1126
GP-2250
WM-S1-001
CT-413
BAY-2416964
KA-2507
AbGn-207
JNJ-64164711
OCP-2101
Sutinib(Jiangsu Maidu Pharmaceutical R & D Co Ltd)
CS-24123
BOS-172722
REIC gene therapy(Momotaro-Gene Inc.)
Baltaleucel-T (CAGT/Kuur Therapeutics)
EF-009
BLYG-8824A
SynOV 3
MDR gene transfer(bluebird bio, Inc.)
1ST-201
LP-002(Guangzhou Lintonpharm Co Ltd)
GliomaGlioblas peptide vaccine(Glioma Actively Personalized Vaccine Consortium)
RG-2833
LEAF-1704
Dubermatinib
MDNA 109 LA
Farnesyl di methyl chromanol(Demelle Oncopharma)
HCW-9207
Atu-027
IN-B010
RGT-X
KF-1603
ABBV-184
EG-Vac
Double-deleted Vaccinia Virus Plus CD/ SMR
LOX-24350
MPD-003
TA-25
N-Acetyl GM3 vaccine (Recombio)
Neutrophil based leucocyte infusion therapy (LIfT BioSciences)
Senl-003
BPI-43487
LEAF-1401
AAVLP HNC vaccine (2A Pharma)
BT-1769
Autologous-HER2-specific-T-cells
SIM-203-2
CSPCHA-131
IN-A008
IDH-305
E-7090
Cancer therapeutics(Ipsen SA)
AIV-001
PRO-1176
KiroVAX 002
LNP-3794
DZ-1004
COF-005
TSC-200
MK-1454
Anti-CD70 CAR T cell therapy(Allogene Therapeutics, Inc.)
dSLIM
Alpha 4CB 1.2
Interleukin-2 gene therapy(St. Jude Children's Research Hospital, Inc.)
XP-104
LASN-02
Radotinib Dihydrochloride
TriMix MEL
YHC-2115
9-ING-41
ENOB-DC-21
YH-29407
N-830
WM-P1
AK-1225
AT-104
TPX-0131
Demegel
PBF-1129(Palo Biofarma SL)
BJY-809
ISA-102
AAV based gamma delta T cell therapy (Expression Therapeutics)
PAN-301-1
WPD-101
BM7PE
IN-A009
VT-03510
TVI Pancreas 1
KY100001
KFP-H019
TBX-3400
ISA-103
GP-01CR01
MRTX-4646
tTF-NGR(University of Münster)
V3-P
CT-179
ASP-0113
CIDeCAR
FF-1027T
Peptidoglycan complex of spirulina(Hwealth Pharmaceutical)
LMY-920
GS-6201
CD123-CD33 cCAR T cell therapy(iCell Gene Therapeutics, Inc.)
Chloroxoquinoline
SB-11312
8-Cl-Ado
OX-413
Multi-specific T-cell engager (Molecular Partners AG)
CEQ-508
RJV-001
CC-10015
N-008
SYN 001 (Avidea Technologies)
3-crx-98
IMA-970A
GLX-5
HLX-52
E6/E7 RNA liposomal vaccine(BioNTech SE)
Mebiphon
Ralimetinib dimesylate
YS-ON-002
DN-022
Autologous EGFR-CAR T cells(Sun Yat-Sen University)
CC-115
SHC-024
CPI-203
HDT-104
ATB-301
ZL-2201
Simmiparib
ADP-c165
Adenine
GO-3C7
GLR-2007
GEN-3014
BMC-121
Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells(City of Hope National Medical Center)
UniCAR02-T
HJ197
SY-010
DHODH 2
Betatinib
XNTR-934
ERG-245
BPM-42522
OCV-101
XP-105
NADI-351
AV-GBM-1
LOP-002
Stapuldencel-T
ADC-3
PHI-301
JNJ-38877618
VRN-061782
14C-波齐替尼
甲磺酸哆希替尼
ARS-1620
BPI-421286
MRTX-1257
ASP-2453
RG-6330
APG-1842
RMC-9805
HS-438
PF-114
NRX-0492
KIN-8194
Danusertib
CHMFL-ABL-039
ZYBT-1
AU-10458
AU-8653
ERAS-3691
ERAS-4057
ICP-915
IMC-KRAS-G12D
KP-14
RM-018
RM-007
RM-008
WDB-178
YF135
MZ-001
SIAIS-126
RM-032
PK-083
PK-9318
FWD1509 MsOH
NIP-142
DS-2087b
MLM-CAR44.1 T-cell therapy(MolMed)
4SCAR-CD44v6
MB-710
MB-725
14C-labeled poziotinib
PNQ-154
AS-1266
KST-016366
CB-988
TGRX-678
XMU-MP-3
S-116836
GZD-856
KF-1601
HS-543
CHMFL-ABL-121
UM-9107
CHMFL-48
BEBT-108
BLU-4810
CHMFL-EGFR-202
GRN-1301
OBX1-012
SKLB-1206
TAS-2913
TGRX-360
YL143
Transtinib
XZP-5809-TT1
Doxitinib mesylate
WZ-4002
SIAIS-125
DDC-01-163
DY-3002
CHMFL-EGFR-26
C-005
JFAN-1001
HCW-9218
p53-oligomer inhibitors(Treventis Corp)
second generation p53 reactivators(Aprea Therapeutics)
CB-002(Pennsylvania State University/Fox Chase Cancer Center)
microRNA-34a(the Chinese University of Hong Kong)
STB(Fudan University)
TAR-1
oxaliTEX
FL-118
miRNA-based p53 modulators(InteRNA Technologies)
macrocyclic peptides targeting p53(Circle Pharma)
p53-expressing oncolytic adenoviruses(ORCA Therapeutics)
MDM2 inhibitors(Adamed Group)
ATRN-502
mutant p53 reactivators(Northwestern University)
CB-001(Fox Chase Cancer Center)
CTX-1(MiRx Pharmaceuticals)
p53 restoring therapeutics(University of California, Irvine)
DWP-0016
AG-1031
TB-055
SAL-009
VSV-GP-CCL21
BT-102(Chengdu Brilliant Pharmaceutical)
ASK-712
BT-101(Chengdu Brilliant Pharmaceutical)
IGF1R inhibitors(Boehringer Ingelheim)
VSV-GP
EBI-1266
BI-93
APG-1022
HD-1906
XZP-P118
RAR-related orphan receptor gamma agonist(Eternity Bioscience)
D-0011
HD-1902
LXSH-ND004
KM-119
LXSH-ND003
PLAT-001
OB-510
histone acetyltransferase inhibitors(Boehringer Ingelheim/ Epizyme)
ASC-63
non-cyclic dinucleotide STING agonist(Eternity Bioscience)
EGFR inhibitors(Jiangsu Aosaikang Pharmaceutical)
ASK-965
GM-05
p53-Mdm2 binding inhibitors(Priaxon/NexusPharma/Boehringer)
ZD-55-IL-24
c-Met inhibitor(Jiangsu Aosaikang)
dual EGFR/HER2 inhibitors(Jiangsu Aosaikang Pharmaceutical)
small cell lung cancer therapy(Heifei Heyuan Pharmaceutical/NovoTek Therapeutics)
DT-13
SM-1(Central South University/Guangzhou BeBetter Medicine Technology/Shenzhen Zhenxing Pharmaceutical)
LXSH-ND007
HDSY-313
B-raf V600E inhibitors(Eternity Bioscience)
SAL-012
LXSH-ND002
SAL-010
HD-1903
CD73 checkpoint inhibitor(Eternity Bioscience)
ASK-1296
CJ-2360
BT-113
anticancer therapy(Apeloa)
Neo-MASCT(HRYZ Biotech/The First People's Hospital of Lianyungang)
CDK4/6 inhibitor(HaiHe Biopharma)
helicase inhibitors(Boehringer Ingelheim/Epizyme)
PROTAC-based MDM2 degrader(Ascentage Pharma)
EBI-1051
LXSH-ND006
SAL-006
CDK1/4/6 inhibitor(Shanghai Haihe Pharmaceutial)
OX-40激动剂（上海挚盟）
靶向Survivin DC细胞
聚糖铁复合物
多西他赛/利托那韦
薄荷脑
氯乙环磷酰胺
纳扎替尼
注射用重组抗HER2人源化单克隆抗体(特瑞思)
BAY-2927088
Dendritic cell vaccine(Medigene Immunotherapies GmbH)
Azeliragon
P-2003
PR-401
dPLTs-01
dPLTs-02
CLDN18.2 UCAR-T(Suzhou Maximum Bio-tech)
HLX-58
BNT-212
SPX-101(SparX Biopharmaceutical)
IM92
HC-7366
YT-claudin18.2
OX-40 agonist(zhimeng Biopharma)
Immuno-oncology(iPSC Platform) Program (Metagenomi, Inc.)
ZXBT-1158
BEBT-260
Allogeneic iPS-derived NK-cell based gene therapy
MAX-10181
LYL-132
Induced pluripotent stem cells NK cell therapy (Jacobio Pharmaceuticals)
Induced pluripotent stem cell based neutrophil based leucocyte infusion therapy (LIfT BioSciences)
BP-2201
FT-538
StemVacs-V iPSC derived dendritic cell immunotherapy (Therapeutic Solutions International)
Pan-KRAS Program (Silagene, Inc.)
GC-027
mRNA-4359
MEDI1191
anti-cancer mRNA therapeutics(Moderna, Inc.)
luteolin
Anti CD147 CAR-T
QLS-31906
LF0397
YL-0007
YL-0010
YL-0022
INV-1703
Anti-CD19/CD22 CAR-T
DetoxPC
THZ-0106
cisplatin/vinorelbine
AVA-101
AVA-201
AK antiVEGF
AAV2hAQP1 gene therapy(National Institutes of Health)
Deoxynucleogene Ancparvovec (CLS Therapeutics)
CD4 CAR T cell therapy(iCell Gene Therapeutics, Inc.)
repurposed imipramine(Ennaid Therapeutics)
n-butyl-2-cyanoacrylate
Targeting Survivin DC Cells
SH003
MAG-TN3 + AS15 vaccine
Polysaccharide Iron Complex
NTO-1151
Colorectal cancer vaccine (Immunovo/Pepscan Therapeutics)
Autologous dendritic cell vaccine (Amphera)
Cancer vaccines (Oxford Vacmedix)
MT-103(Myeloid Therapeutics)
humanized mAb anti-TROP-2 program (Oncoxx)
Ralaniten (ESSA Pharma)
JHU-395
Didox
ARS-853
VE-821
MJC-13
NVP BEP 800
CC-90010
MAGE-A3 vaccine
Fexapotide triflutate(Nymox Pharmaceutical Corp.)
DS-1647
Aganirsen
AS-1411
PTC-299
Telomelysin
RG-7461
Lanraplenib
AMG-397
PL-MLP
Docetaxel/Ritonavir
BEY-1107P
Delimotecan
Apatorsen
Crotoxin
ONC-212
ONC-206
Prexigebersen
ODM-203
Etidaligide
DSP-0509
OXB-301
CKD-581
DS-5010
LASW1510
Menthol
AB003
AB006
GEC-052t
GEC-067t
NSC-620621
Trofosfamide
UA020
UA011
UA022
Collagenase clostridium histolyticum(University of Alberta)
c-myb AS ODN(Abramson Cancer Center of the University of Pennsylvania)
STK-012
IDE-161
RC-01 (Hongyun Biotech)
GCT-02
PD-L1 peptide(Inge Marie Svane,Herlev Hospital)
L-Threonic Acid Magnesium Salt
SYHA-1908
RO-7428731
BAY-568
LNG-451
STX-EGFR-EXON20
AP-L1898
Olafertinib
BLU-5649
Nazartinib
BLU-7650
EAI045
EGFRvIII synNotch CAR-T
LS-106
JBJ-04-125-02
Anti-EGFRVIII CAR-T cell therapy (Yake Biotechnology)
Anti-EGFRvIII CAR-T-cell therapy (Chembrain LTD/University of Oulu)
Anti-EGFRvIII CAR-T cell therapy (Suzhou Maximum Biotech)
EGFRVIII-targeted CAR-T
Anti-EGFRVIII CAR-T cell therapy (Shanghai Unicar-Therapy Bio-medicine Technology)
EGFRvIII CAR-T (NCI)
anti-EGFRvIII CAR T
lamellarin 14
JND-3229
JND-3299
LQ-103
EMI-56
CH-7233163
BI-4020
AZ-7608
XHL-11
UPR-1444
trastuzumab biosimilar(Zhejiang Teruisi Pharmaceutical)
吲哚胺2,3—双加氧酶抑制剂
锝[99mTc]异腈葡萄糖
碘[125I]密封籽源
重组人IL12/15单纯疱疹I型双调控溶瘤病毒(Vero细胞)
泽贝妥单抗
重组全人源抗人表皮生长因子受体单克隆抗体(神州细胞工程)
重组人源化抗PD-1单克隆抗体 (神州细胞工程)
CD19 CAR-T细胞疗法 (中国医学科学院血液病医院)
重组抗CD38人源化单克隆抗体 (杭州尚健生物)
美雄烷
AMX-3009马来酸
泛素特异性肽酶9X抑制剂
自体多抗原特异性细胞毒性T淋巴细胞(深圳益世康宁生物)
非小细胞肺腺癌复合抗原致敏的树突状细胞所激活的自体T细胞(深圳益世康宁生物)
特托莫肽盐酸盐
膀胱灌注用卡介苗
威顺替尼
二价宫颈癌疫苗（沃森生物）
治疗性宫颈癌疫苗（怡道生物）
华蟾素
磷酸二甲吗喃
CT032人源化抗CD19自体CAR T细胞
兰索拉唑/阿莫西林/甲硝唑
康莱特
原创项目1-肿瘤（百放英库）
原创项目2-肿瘤（百放英库）
原创项目3-肿瘤（百放英库）
甲磺酸莱洛替尼
HEC81885对甲苯磺酸盐
靶向CD19自体嵌合抗原受体T细胞 (安徽安科生物)
贞芪扶正
槐定碱
鸦胆子油
清肺散结
健脾化痰
消癌平
肝复乐
胃复春
片仔癀
艾迪
康艾
参芪扶正
复方黄黛
红金消结
人参皂苷Rg3
参红祛瘀散结
KRAS肿瘤疫苗（斯微生物）
急性髓系白血病AML疫苗（斯微生物）
HPV疫苗（斯微生物）
Mitochondrial Carrier Modulators (MitoCareX Bio)
Neocura Ag
Indoleamine 2,3-deoxygenase inhibitor(Innovent Biologics)
HLK-1002
HLK-1004
HS-10386
Alpha fetoprotein targeted T-cell therapy(Adaptimmune Ltd.)
Anti-CD19 UCAR-T cell therapy (Nanjing IASO Biotherapeutics)
RD-201
Anti-TNFR2 monoclonal antibody (HiFiBiO Therapeutics)
HFB-1014
HFB-1018
FB-704A
HFB-3016
HFB-101110
HFB-200902
HFB-100204
GRO beta
SYHX2005
R01
Tumor Infiltrating Lymphocytes (Hebei Senlang Biotechnology)
HFB-200603
Rivipansel Sodium
BMS-986179
177Lu-Ludotadipep
VRP-1620
68Ga-FAPI
[68Ga]CBP8
cRGD-ZW800-1
68Ga-BBN-IRDye800CW
ABY-029
Yttrium-90 (90Y) DOTATATE
18F-C-SNAT4(Stanford University)
RMAs (Eloxx Pharmaceuticals)
[18F]-SKI-249380
68Ga-PSMA-R2(The Johns Hopkins University)
NLS-VPAC1
18F-FluorApoTrace(Washington University School of Medicine)
68Ga-P15-041
177-Lu-DOTA-cG250(Ludwig Institute for Cancer Research)
124-iodine-labeled PSCA targeting minibody(University of California, Los Angeles)
64Cu-DOTA-ECLIi
62Cu-ATSM
99mTc-maraciclatide
[18F] DASA-23
177Lu-AB-3PRGD2
99mTcN-Isonitrile glucose
I-125 Seed Source(Chengdu Yunke)
18F-LY3546117
13C-Methacetin(University of Texas Southwestern Medical Center)
225 Actinium PSMA 617(Novartis Pharma AG)
111In-IPN01087
[203Pb]VMT-α-NET
Tuxobertinib
Farudodstat
Programmed cellular immunotherapeutic (Fate Therapeutics)
Gartisertib
18F-FPPRGD2(Stanford University)
[18F]AA-7
64Cu-DOTA-U3-1287
18F-Fludarabine
64Cu-LLP2A(Washington University School of Medicine)
[68Ga]-FF58
[68]Ga-HA-DOTATATE
18F-PEG3-FPN
LMI-1195
Peptide-based PET radiotracer(Stanford University)
CLR-124
18-F-fluoroacetate sodium
Alpha-emitting radionuclide therapy(Oncoinvent)
[18F]-AzaFol
Technetium (99mTc) Macroaggregated Human Serum Albumin
89Zr-cRGDY Ultrasmall Silica Particle Tracers
68Ga-citrate
111In-CP-04
Recombinant Human IL12/15 Herpes simplex TYPE I dual regulatory oncolytic virus(Vero cell)
68Ga-RMX-VH
DP-3311
AIP-303
DP-5511
MNPR-101-800F
FG-001
SN132D
MetaMx
MPB-1523
Ferumoxtran-10
Rezoskan-99mTc(Pharm-Sintez)
[203Pb]VMT01
Fluorine-18-CTT-1057
18F-Al-NOTA-MATBBN(Wuxi No. 4 People's Hospital)
[18F]FPyGal
Gallium-68 satoreotide
68Ga-NOTA-BBN-RGD
Iron oxide nanoparticle m-PEG-silane(MegaPro Biomedical Co. Ltd.)
THG-009
99mTc-MSA-ICG
LUM-015
99m-TC-PSMA-I&S
PHC-102
18F-MNI-1054
[64Cu] Macrin
177Lu-EB-PSMA-617(National Institute For Biomedical Imaging And Bioengineering (Nibib))
Debio-1124
Lutetium-177 EBRGD(National Institute of Biomedical Innovation)
VM110
Re-188 P 2045
Actinium-225 FAP 2286
OTL-78
CLR1404 I-124
LP-20
Zebituzumab
Anti HLA-G CAR-T Cell Therapy (Invectys)
DSP-216
BR-102
Nuc-Gemcitabine (AptaBio Therapeutics)
VPS34 inhibitors(Deciphera Pharmaceuticals/Sprint Biosciences)
APTA-16
NC-525
Oncolytic virus-based therapeutics (Theolytics)
exoASO-C/EBPB
Oncogene Targets (Codiak BioSciences)
cyclin dependent kinase 2 degraders(Monte Rosa Therapeutics AG)
LP-007
LNL-007
ERAS-5
ERAS-11
ERAS-10
ERAS-2/3
ERAS-3490
ERAS-801
PRT-543
KJ-C1807
αCD27mAb
IOmAb
Cannabinoid based therapies (CNBX Pharmaceuticals)
Malignant melanoma cannabinoid therapeutics (CNBX Pharmaceuticals)
Creserol
Anti-cancer therapeutics (AIkido Pharma/Cedars-Sinai Medical Center)
KRAS G12D inhibitors (Curve Therapeutics)
Ovarian cancer therapeutic (Recursion Pharmaceuticals)
RBN-013209
KSQ-4279
ERAS-9
Fadraciclib
Novel checkpoint (T/NK cells) (Celsius Therapeutics)
Lassen mAb program (Celsius Therapeutics)
CE-005
Ledenika mAb program (Celsius Therapeutics)
CRC collaboration (Celsius Therapeutics)
ABBV-453
TT-01488
GL ONC2
HPV 16 E7/HSP70 fused DNA vaccine(The Johns Hopkins University)
AMG-650
PY-265
Inobrodib
DSP-0692
JAB-24114
Isunakinra
JAB-30000
TST-010
MLN-133
NC-1
Cancer therapeutics program(Kymera Therapeutics/Vertex)
Cellgram-ED
anti-CDH17-based antibody drug conjugates(ProAlt)
E-7820
ICP-B05
Demupitamab
Finotonlimab
MRTX-9768
3-CLA
Hypoxia inducible factors inhibitors (Curve Therapeutics)
FOXA1 inhibitors (Curve Therapeutics)
Cannabichromene
Halogenated xanthene
Bifunctional PD-L1-Targeted Sialidase (Palleon Pharmaceuticals)
Autoimmunity modifying proteins (Aeterna Zentaris/Julius Maximilians University)
XL-114
WBP-3425
Urelumab
PROTAC Mcl1 degrader-1
PROTAC ERRα Degrader-2(Jinan University)
PROTAC IRAK4 degrader-4(Kymera Therapeutics)
PROTAC IRAK3 degrade-1(AstraZeneca)
PROTAC IRAK4 degrader-6(Kymera Therapeutics)
PROTAC IRAK4 degrader-5(Kymera Therapeutics)
PROTAC IRAK4 degrader-1(Kymera Therapeutics)
PROTAC IDO1 Degrader-1(Sichuan University)
PROTAC ERRα Degrader-3(Jinan University)
β-NF-JQ1
XZ739
QCA570
PZ703b
PROTAC Sirt2 Degrader-1(University of Freiburg)
SHP2-D26
TL13-112
SJFα
XY028-140
TL13-12
TL12-186
Thalidomide-NH-CBP/p300 ligand 2(Cullgen)
SJFδ
SIAIS178
PROTAC SHP2 degrader-1(Tongji Medical College of Huazhong University of Sci & Tech)
VZ185
TD-165
TD-428
PROTAC ER Degrader-4(AstraZeneca AB)
PROTAC ERRα Degrader-1(Jinan University)
PROTAC CRABP-II Degrader-1(Mercachem BV)
PROTAC EED degrader-2(AstraZeneca)
PROTAC ER Degrader-3(Genentech)
PROTAC BRD9 Degrader-4(Novartis AG)
PROTAC CRABP-II Degrader-3(Mercachem BV)
PROTAC BRD9 Degrader-3(Novartis AG)
PROTAC ERα Degrader-1(Genentech)
PROTAC PARP1 degrader(Tsinghua University)
PROTAC PD-L1 degrader-1(Southern Medical University)
PROTAC RIPK degrader-2(Yale University)
PROTAC RAR Degrader-1(Mercachem BV)
PROTAC RIPK degrader-6(GlaxoSmithKline)
PROTAC BRD4 Degrader-2(China Pharmaceutical University)
PROTAC BRD4 Degrader-1(China Pharmaceutical University)
MS432
MZP-55
PROTAC BRD4 Degrader-13(Genentech)
MS21
PROTAC BET degrader-2(University of Michigan)
MS4322
MD-222
PROTAC BRD4 Degrader-10(Genentech)
PROTAC Bcl2 degrader-1(Dalian University of Technology)
MS98
OARV-771
PROTAC BRD4 Degrader-3(Genentech)
PROTAC BRD9 Degrader-1(Dana-Farber Cancer Institute)
PROTAC BET Degrader-10(Dana-Farber Cancer Institute)
MZP-54
MG-277
MS33
KB02-SLF
PROTAC BRD4 Degrader-15(Genentech)
PROTAC Bcl-xL degrader-3(The University of Central Florida Research Foundation)
Pomalidomide-C5-Dovitinib
PROTAC BRD4 Degrader-9(Genentech)
MS67
PROTAC BRD4 Degrader-5(Imperial College London)
PROTAC B-Raf degrader 1(Southeast University)
MS4077
PROTAC BRD4 Degrader-7(Genentech)
PROTAC BRD4 Degrader-12(Genentech)
PROTAC CDK9 degrader-2(China Pharmaceutical University)
PROTAC CDK9 degrader-4(Shanghai Institute of Materia Medica Chinese Academy of Sciences)
PROTAC BRD9 Degrader-2(Novartis AG)
PROTAC CDK2/9 Degrader-1(Sichuan University)
PROTAC CDK9 Degrader-1(University of Nebraska Medical Center)
PROTAC CRBN Degrader-1(University of Dundee)
HDAC6 degrader-1(Tsinghua University)
ZXH-3-26
dFKBP-1(Dana-Farber Cancer Institute)
FKBP12 PROTAC dTAG-7(Dana-Farber Cancer Institute)
UNC6852
SJF-620
SD-36
PROTAC CBP/P300 Degrader-1(Cullgen )
PROTAC FAK degrader 1(Yale University)
CRBN-6-5-5-VHL
CP5V
BSJ-4-116
BSJ-03-123
BI-3663
BETd-260
FKBP12 PROTAC RC32(Tsinghua University)
ERD-308
INY-03-041
Homo-PROTAC cereblon degrader 1(University of Bonn)
KB02-JQ1
JH-XI-10-02
GMB-475
FKBP12 PROTAC dTAG-13(Dana-Farber Cancer Institute)
dMCL1-2(University of Calgary)
dCBP-1(Harvard Medical School)
THAL-SNS-032
BETd-246
AT6
AT1
A1874
AU-15330
ARD-2128
ARCC-4
dTRIM24(Dana-Farber Cancer Institute)
Gefitinib-based PROTAC 3(Yale University)
dBET23(Dana-Farber Cancer Institute)
BSJ-03-204
MD-224
dBET1(Dana-Farber Cancer Institute)
dBET57(Dana-Farber Cancer Institute)
KRAS targeting PROTACs drug
CP-10
BSJ-04-132
MT-802
dBET6(Dana-Farber Cancer Institute)
SER-203
POZ-LNPs(Serina Therapeutics)
Anti-CD19 CAR-T cell therapy(Hematology Hospital of Chinese Academy of Medical Sciences)
IMM-6-415
SJ995973
SIM1
SJ10542
NXP-800
LNS-8801
Threitolceramide 6 (Portage Biotech)
PORT-4
PMD-026
ORIC533
PLK4 inhibitor (ORIC Pharmaceuticals)
TK-216
PORT-5
BBT-207
MB-101(Mustang Bio, Inc.)
BAL0891
KD-496
KD-593
Ubilical cord blood derived NK cell therapy (Affimed)
ABN-501
ALE-C04
QL-1779
Insulin (Rezolute)
Hepavac(In-Cell-Art)
PLGAI03
PLGAI04
Small molecule therapeutic (Insilico Medicine/BioNova Pharmaceuticals)
ISM004-1057D
PTT-3213
PTT-3196
MB-109
CARVac Claudin6 mRNA vaccine(BioNTech)
SC-291
SC-255
SG-295
SG-242
SG-221
SG-239
PMC-402
PMC-403
PMC-309
PROTAC KRAS G12C degrader-1(Dana-Farber Cancer Institute)
Modi 1
PROTAC EGFR degrader 2(China Pharmaceutical University)
PROTAC BRD4 Degrader-8(Genentech)
PROTAC CRABP-II Degrader-2(Mercachem BV)
LT-005
LT-004
LT-003
HS-236
PROTAC ER Degrader-2(Genentech)
HGN002
HGT04
HGT05
HGT03
HGT02
HGT01
HGN001
HGP2142
255 Ac-rhPSMA-10.1
NXP-900
ATYR-2810
CYT-503
CYT-538
CYT-150
PROTAC Bcl-xL degrader-2(GlaxoSmithKline)
JB170
Cancer therapeutics (Aria)
NSCLC therapeutics(Aria/SK Biopharmaceuticals)
1ST-205
PROTAC AR Degrader-4(The University of Tokyo)
PROTAC Bcl-xL degrader-1(University of Florida)
PROTAC AR-V7 degrader-1(Acharya Nagarjuna University)
MS83
Perfluorocarbon oxygen carrier
WRN therapy (Ryvu Therapeutics)
PRMT5 therapy (Ryvu Therapeutics)
SG-3-00802
STING therapy (Ryvu Therapeutics)
CA-327
CA-170
SQZ-eAPC-HPV
INCB-086550
SMP-215
Drug Conjugates (Xiling Lab Pharmaceutical Co. Ltd.)
TNX-1700
MVA-209-FSP
MTL-STING
KAL-21404358
DP-C-4
GSK215
HPK1(CULLINAN ONCOLOGY, LLC)
CLN-619
ORM-5029
SG-1409
CIP-137401
Pol theta inhibitor ( Repare Therapeuctics)
DAV-132
DM002
MT-201(Myeloid Therapeutics)
CBL B inhibitor (HotSpot Therapeutics)
ONCR-021
ONCR-788
Androgen receptor antagonists (ESSA Pharma)
Next-generation EGFR inhibitors (Theseus Pharmaceuticals)
HER2-ATAK cells (Myeloid Therapeutics)
ME-344
CD8-IL21(Asher Biotherapeutics)
OR-449
SON-1210
RXC-004
Autophagosome vaccine(UbiVac LLC)
ON203
MHB008C
ATG-012
AU-007
NX-0255
AGB1
Recombinant human anti-CD38 momoclonal antibody(Hangzhou Sumgen Biotech Co. Ltd.)
WTX-613
RC-06
MSB-0254
ARV-825
ARV-771
LC-2
Mepitiostane
Frenlosirsen
Target 2 (Biomea Fusion)
CBP-1018
P28z-CAR
InCVAX
Camptothecin
CT-01
ARVN-71228
BTX1344
SMARCA2 inhibitors(Arvinas/Genentech)
CFT-8919
CT-02
ZNL-02-096
CFT-2718
FIM-001
Folate-MS99
MS154
SP4
PROTAC-based Bcl-xL degrader
PROTAC-O4I2
FA-S2-MS4048
GNE-0011
Folate-MS432
MS39
irucaparib-AP6
WB-214
UI-EP001
UI-EP002
MD13
ARD-2585
ARD-69
SJF-0628
RBN-012811
MS910
MTX-23
E3 ubiquitin ligase based protein degradation(GSK/Kymera)
KT-253
MS934
MS928
Anticancer Peptides PL-AC(Jiangsu Protelight Pharmaceutical & Biotechnology)
AMX-3009 Maleate
AMX-5035
AMX-6001
Ubiquitin Specific Peptidase 9X Inhibitor(FORMA THERAPEUTICS)
TAB006/JS006
PRT-SCA2
PRT-K4
CDK2 targeting medicine(Monte rosa)
KTX-201
Cancer therapeutics program(C4 therapeutics)
Cancer therapeutics program(C4 therapeutics/Roche)
Cancer therapeutics program(A2A pharma)
A2A-02
A2A-04
Oncology program(Arvinas)
Myc targeting PROTACs
OPAL-0012
USP7 inhibitors (Medivir)
USP7 inhibitors (Almac Discovery)
ASC60
IPS-Induced NK Cell
Anti CD22 chimeric antigen receptor T cell therapy(Shanghai YaKe Biotechnology Co Ltd)
CAR-T EGFRvIII
TWP-103
GF-109
SRF-114
DS-1205(Daiichi Sankyo Co. Ltd.)
Anti-CDH17 mAbs (ProAlt)
DYV800
CHM-2301
Her2/Neu-LAMP DNA vaccine(Immunomic Therapeutics)
IGM-8444
Ace-HK20
ATRN-119
YK012
kt-3000 Dual Action DDR-inhibitors (Rakovina Therapeutics)
kt-2000 next generation PARP inhibitors (Rakovina Therapeutics)
kt-4000 DNA Damaging DDR-inhibitors (Rakovina Therapeutics)
LB2102
LB1905
LB1910
LB1902
Matrix metalloproteinase 13 inhibitors (Moffitt Cancer Center/Florida Atlantic University)
Autologous multi-antigen specific cytotoxic T lymphocytes(Immuclin Biomed)
Dendritic cells activated autologous T cells(Immuclin Biomed)
HP-530
HC-X035
HC-X027
HP-537
AMC-303
Heberprovac
Nccv cocktail-1 vaccine
Tertomotide hydrochloride
AK-117
TTX-MC-138
TTX siLIN28b
NAV-003
NAV-205
NAV-201
Allogeneic genetically engineered human umbilical vein endothelial cells (Angiocrine Bioscience)
Anti-CD40 antibody (Biosion)
Anti-HER2 Antibody (Biosion)
Anti-SIRPα Antibody (Biosion)
HPG4980
Acurita
HDAC6 inhibitors (cancer) Sichuan University/Guangdong Zhongsheng Pharmaceutical Co Ltd
E-191
HY027
HBW-005
HBW-010
HBW-008-A
HBW-012
GTAEXS-617
Cancer therapeutics(Exscientia/GT Apeiron )
BCG for Intravesical Instillation(China Medical System)
Piclidenoson
Bizalimogene ralaplasmid(University of Pennsylvania)
PRTX-007
NAV-004
Rituximab biobetter (Navrogen)
Roneparstat
NTX-2R13
ACU-D3
HXL-07
Anti-GD2 CAR-T therapy(Beijing Sinobioway Bioengineering Group Co Ltd)
Anti-EPCAM CAR-T cell therapy(Beijing Sinobioway Bioengineering Group Co Ltd)
INBRX-121
LS-2113
Weersuntinib
Human papillomavirus vaccine recombinant bivalent (Shanghai Zerun Biotechnology)
EVER-4010001
rHSV 1 APD1
ICG-180
Viral Driver Program: MCPyV (Affini-T Therapeutics, Inc.)
Karonudib
CIK-CAR PSMA(Formula Pharmaceuticals)
CIK-CAR.CD33(Formula Pharmaceuticals)
Belvarafenib
FHND5071
Uterine Cervical cancer vaccine for therapeutic use(Yidao biotechnology)
Cancer immune evasion therapies(Tango therapeutics/Gilead Sciences)
STK11-mut lung cancer therapeutics(Tango Therapeutics)
SY-5007
SY-4798
AVB-004
AVB-005
AVB-003
Cinobufacin
CT-04
CT-05
CT-03
RS-0625
RS-0735
RS-0337
RS-0461
INB 200 (IN8bio)
CMD-505
WU-NK-201
GINAKIT-Cells
EB1006
EB1007
EB1005
QHRD102
Anti-CD27 monoclonal antibody (Kineta)
BND-35
CURB-906
OSE-279
BNT-116
LAVA-1278
ICT-04
OST-TDC Folate Receptor (OS Therapies)
VCN-11
AVX420
Dactolisib
Dimemorfan Phosphate
LN-145-S1
IOV-2001
MTB-9655
ODN/Pam2
Project 2(Small molecule drug conjugate)(Canwell)
Project 3(Small molecule drug conjugate)(Canwell)
Project 4(Small molecule drug conjugate)(Canwell)
Viral Vaccine Adjuvant(Nasopharyngeal carcinoma)(Canwell)
Project 1(Immuno-oncology)(Canwell)
CMN-001
SMART-101
Cancer Vaccine (TechnoVax)
SMART-401
CBP-1088
CBP-2008
CBP-1068
CBP-1019
WTX-330
ELU-002
ELU-003
ELU-004
ELU-005
VTX-003
CBP-1029
RanTop(Orgenesis)
ORGCAR19.22(CD19.22 CAR-T)(Orgenesis)
ORGCAR19(CD19 CAR-T)(Orgenesis)
MOTC(Orgenesis)
KRAS G12C inhibitors (Leidos Biomedical Research)
KRAS G12C inhibitors (Shenzhen Forward Pharmaceuticals)
KRAS G12C inhibitors (Frontier Medicines)
KRAS G12D inhibitors (Leidos Biomedical Research)
Small molecular therapeutics(Exscientia/Bayer)
Cancer therapeutica(Exscientia/Huadong Medicine)
Cancer therapeutics (Exscientia/EQRx)
Cancer therapeutics(Exscientia/Bristol Myers Squibb)
SIWA-318
Ovarian cancer vaccine (Anixa Biosciences/Cleveland Clinic/NIH)
FL776
FL923
FL926
vMYX-hIL-12/Dec (OncoMyx Therapeutics)
FL7729
WSX15
FL7736
FL762
FL7724
WSX2
FL779
FL763
FL496
FL7727
FL7728
FL922
JT-15
FL761
JT-21
OM4
Breast cancer vaccine (Anixa Biosciences/Cleveland Clinic)
Oncolytic adenovirus(Vesselon)
KROS-201
MDT201
RT003
MB-097
Bispecific Small Molecules(Exscientia/Sanofi)
HC101
HC106
SIM-235
SCR-6106
BC-3402
SCO-201
EMDR001
MDR033
EXS-21546
MDR002
dual A2aR checkpoint inhibitor/CD73 checkpoint inhibitor(Exscientia/Evotec)
Doxorubicin liposomal
Octreotide oral film(Connexios Life Sciences Pvt Ltd.)
MRTX-1133
TQB3804
KROS-101
BBP-954
KROS-301
KROS-102
PC-002p
CTB-05
CTB-02
ZTR
ST-1839
CX510
QL415
AUR103
UD001
UD003
UD002
UD004
UD005
IMP17
IMP13
IMP12
PLX-4107
CT017
Anti-CD19 chimeric antigen receptor T cell therapy (CARsgen)
CT-3417
CT-2426
CT-1803
CT-1995
CT-2755
CT-1495
SY-1530
CT-1139
Tuvonralimab
Iparomlimab
GNUV204
ONC-841
JZP-815
Merional
SCB-333
SCB-340
SCG142
SCG102
SCR-6992
SCR-8079
3D197
ADG206
SCR-6277
SCR-7952
SR065
Lansoprazole/Amoxicillin/Metronidazole
SG404
iPSC-NK(CellOrigin Technology (Hangzhou) Co. Ltd.)
IMC-003
IMP5471-CA
Kanglaite
NC001
E-602
XZP-P283
XZP-P107
XZP-P270
XZP-P291
XZP-P294
XZP-P280
JWATM203
JWATM214
Nex-G
JWATM213
project 1-oncology(biofront therapeutics)
project 2-oncology(biofront therapeutics)
project 3-oncology(biofront therapeutics)
IN20130
[F-18]RGD-K5
UCT-03-008
WHG626
IMT-001
Lorpucitinib
IRE1alpha inhibitors (OptiKira)
GNKS-356
CPI-100
Gal-300
OXO-001
ADP-399
CB5138-3
AN-3015
INV-240
MB-204
SPL-891
MB-6
DRP-104
CT-859
SAMiRNA-AREG
FGH-10019
LP-103
YY-002
VK-2019
AgenT-797
Ingenol Disoxate
Cannabigerol
CT-365
HEC89736PTSA·0.5H2O
Larotinib Mesylate
HEC81885 Tosylate
TY-302
TY-1036
TY-2136
ABSK-061
GC019F
BEBT-209
BLR100
AB002
Dapansutrile
SSI-4
CFI-402411
NGM-831
ACT-01
HX-s004
HX-s003
CD19-CAR-T cell therapy(China Immunotech Co. Ltd.)
CD19-STAR-T cell therapy(China Immunotech Co. Ltd.)
DF6002
ATAP-M8
SCTX001
TRS007
CS-3002
BLU-451
Nimustine Hydrochloride
hydroxycamptothecine
Aclarubicin Hydrochloride
Anti-CD123 CAR T-cell therapy(Nanjing Legend Biotechnology Co. Ltd.)
Vindesine Sulfate
HRS-3658
DB108
RJ4964
PCAR-019(Anhui Anke Biotechnology (Group) Co. Ltd.)
adenoviral methioninase gene therapy/selenomethionine GDEPT (AntiCancer Inc)
ZhenQifuZheng
sophoridine
Brucea Javanicaseed Oil
QingFeiSanJie
jianpi huatan (dispensing granule)
XiaoAiPing
GanFuLe
WeiFuChun
PianZiHuang
AiDi
KangAi
SQ001
Realgar-Indigo naturalis formula
HongJinXiaoJie
ginsenoside Rg3
ShenHongQuyusanJie
Boric acid
KRAS Cancer Vaccine(Stemirna Therapeutics Co. Ltd.)
Acute myeloid leukemia (AML) Vaccine(Stemirna Therapeutics Co. Ltd.)
HPV vaccine( Stemirna Therapeutics)
宫瘤消胶囊
抗人CD19-CD22 T细胞疗法(恒润达生)
表皮生长因子癌症疫苗(Center of Molecular Immunology)
重组人源化单克隆抗体MIL98
重组抗PD-L1全人单克隆抗体 (上海复宏汉霖生物)
重组全人源抗PD-L1抗体 (桂林三金药业)
重组人源化和Fc改造的抗程序性死亡配体1 (PD-L1)单克隆抗体 (苏州迈博斯)
重组人源化抗PD-L1单克隆抗体/人TGF-β融合蛋白(乐普生物科技)
重组抗PD-L1全人源单克隆抗体(江苏怀瑜药业有限公司)
重组人源化抗PD-L1单克隆抗体 (上海君实生物)
重组抗LAG-3人源化单克隆抗体注射液 (上海复星医药)
重组抗PD-1全人源单克隆抗体 (石药集团中奇制药 (石家庄))
布格利单抗
重组抗PD-1全人源单抗 (东阳光)
重组抗PD-1人源化单克隆抗体 (安徽安科生物)
重组人源化抗PD-1单克隆抗体(山西威奇达光明制药有限公司)
食道平散
重组人源化单克隆抗体MIL95 (北京天广实生物)
重组人源化抗CD47单克隆抗体(乐普生物)
FLT3-Fc融合蛋白
埃拉利单抗
锝[99mTc]肼基烟酰胺聚乙二醇双环RGD肽
HLA-A*0201 Restricted Antiangiogenic Peptide Vaccine
BPI-442096
recwt1-A10 adjuvant with AS01B
Gongliuxiao Capsule
CD19/CD20 CAR-T Cells
YBL-003
Anti-CTFG RNAi therapy
JS209
PM-1021
PH 804 ACT NK Cell therapy (Phio pharmaceuticals)
DSP-502
SL-9258
NY-ESO-1 TCR (Kite Pharma)
Anti-NY ESO 1 CAR-T cell therapy (Eutilex)
Anti-NY-ESO-1 CAR-T cell therapy (Shenzhen BinDeBio)
DUK-CPG-001
FPI-1175
EGFR806 CAR-T Cell(Seattle Children's Hospital)
EGFR806 CAR T Cell Immunotherapy(Seattle Children's Hospital)
QLS31901
N-809
AdMA3
YH-BIO2
LSD1/HDAC6 dual inhibitors(Jubilant Therapeutics)
Recombinant fowlpox-prostate specific antigen vaccine
MAA-C001
Protein arginine N-methyltransferase 5 inhibitors(Jubilant Therapeutics)
New Castle Disease Virus
ONCOS-211
I-022-K
CIN3 Theraputic Vaccine
VERI-105
MT-1201
PET-flourescence biomodal imaging agent (ER-positive breast cancer)(Capital Medical University)
ABP-008
CEA peptide 1-6D
VERI-103
VERI-102
CpG-MCL vaccine
RGS-371
SERMs(CEAMED)
MFA-370
AL-009
BSB-1001
HER2 vaccine therapy(International Cancer Laboratory)
Tri-functional proteins(KAHR Medical)
NP107
RGS-365
Bryostatin-23
CyPep-1
VERI-104
[131]ICF01012
MSC11FCD
iPSC-derived natural killer cells plus monoclonal antibody(CellOrigin Technology (Hangzhou) Co. Ltd.)
IDO-derived peptide vaccine/PD-L1-derived peptide vaccine
DP-053
VEGFR1-A24-1084
NeoAg-mBRAF
Anti-CD19 anti-CD22 bispecific chimeric antigen receptor T cell therapy(Hrain Biotechnology Co. Ltd.)
HLA-A02 restricted HIG2
PD-L1 inhibitors(Jubilant Therapeutics, Inc.)
Multispecific T cell receptor mimic antibody based T cell engagers(Biocytogen Pharmaceuticals/CTM Biotech)
NBRI16716A
AccuVAC-PTE7
NEU001
SAR444881
Deuterated Plinabulin (Marine Biomedical Research Institute of Qingdao)
BAT-1308
Anti-CD30 CAR-T cell therapy (Nanjing IASO Biotherapeutics)
Anti CD30 CAR-T
CD30.CAR
EBV-specific-CAR.CD30
SP-3164
Trastuzumab biosimilar(CuraTeQ Biologics)
NOUS PEV
XZB-001-003
CN-401
HS-130
Human papillomavirus vaccine(Ruprecht-Karls-University of Heidelberg)
GT-19630
CUG-105
JS-120
GB-267
TAY-018
CUG-115
JNJ-1330
CB-101
MDNA 109 FEAA
CUG-172
F-527
CHS-1000
JS-122
CUG-288
Tri-specific natural killer-cell engagers(Merck)
B-006
JS-123
JNJ-6358
CB-132
S-095033
HM-99462
TEP-118
PRO-1106
YDB-102
AVA-028
APB-R5
CHS-3318
APB-BS2
BVX-0922
CB-114
FMPV-2
RAS inducers- Immuneering(Immuneering)
CUG-222
YDB-201
CUG-279
HST-1011
GB-3010
KRLS-017
GB-3015
CB-137
JS-121
ErbB4-targeting monoclonal antibody(YUMAB)
APB-D1
Vacuolar protein sorting-associated protein 4A inhibitors(Calithera Biosciences)
ELI-003
Amphiphile-CpG
177 lutetium PNT 2004
ADP-TILIL7
Epidermal growth factor cancer vaccine(Center of Molecular Immunology)
HB-0030
CUG222
CUG172
CUG115
CUG279
CUG-185
CUG105
CGU288
VCAP-102
AB-308
Domvanalimab
Etigilimab
CD47/CD20 inhibitor therapeutic(Bristol Myers Squibb)
JRF-103
GIGA-564
VT-01066
TSRF-786C
VT-02122
Targeted T-cell therapy (Benhealth Biopharmaceuticals)
BAY-405
IN-A006
VT-01290
VT-01300
Adenosine receptor antagonists (AdoRx Therapeutics)
cancer therapeutics project (iLab)
Neumonco drug conjugate (Pneumagen)
IM-003
Anti-CD22 CAR-T-cell therapy (PersonGen BioTherapeutics)
OrcaGraft(Orca Biosystems, Inc.)
ZSP-1603
anti-FLT3 CAR-T
GB-3007
TOT-402
GRC-54276
Anti-GD2 chimeric antigen receptor T cell therapy(Pell Bio-Med Technology)
Gene editing therapies(Myeloid Therapeutics/Prime Medicine)
NGM-438
RH-324
TC-510
BTX-1188
KT-413
HSK-29116
LYN-00202
3D-062
Avutometinib
anti-LAG-3 antibody
anti-TIM-3 antibody
anti-TLR4 antibody
anti-STING antibody
RNAi therapeutics (GeneCare)
AM-401
K20
aKRAS G13D (Oblique Therapeutics)
JAB-21000
BI-2852
OC-211
GEC-255
KRAS G12C inhibitor (BeiGene)
SIM0317
LT-2003
Covalent MEK inhibitors(Immuneering)
KRAS4B inhibitors(Immuneering)
Recombinant anti-CD73 fully human monoclonal antibody
CNS disorder therapeutics(Alkermes)
TargetImmuniT
Immunotherapeutics(Egle Therapeutics/Egle Therapeutics)
Autologous anti-KRAS G12V mTCR gene-engineered cell therapy(National Cancer Institute)
Affini-T
ERAS-4
aKRAS G12V(Oblique Therapeutics)
aKRAS G12D(Oblique Therapeutics)
Monoclonal antibody therapeutics (Eisai Inc)
Therapore-based vaccines
TK-002
VRTX144
MIL-98
FTL-001
RNA tumor vaccine(First Affiliated Hospital Bengbu Medical College)
AZD4625
K-Ras based vaccine(ASCENDO Biotechnology)
LXH005
mDC3/8-KRAS vaccine(University of Pennsylvania;)
NY0244
NY0331
RM-041
RM-036
OVM-400
NY0335
KD-8
COTI-219
Pooled mutant-KRAS peptide vaccine(The Sidney Kimmel Comprehensive Cancer Center)
XNW-14010
TK-2504
Pertuzumab biosimilar (Biocad)
BCD-223
MP-0533
Anti-EGFR-bispecific antibody armed activated T-cell therapy(Memorial Sloan-Kettering Cancer Center)
ONC-895
HPK1 Protein Degrader(Cullinan)
manelimab
Durvalumab/Gefitinib
Durvalumab/Selumetinib sulfate
LVGN-1673
SCR-1105
Lodapolimab
HLX-20(Shanghai Henlius Biotech, Inc.)
AC-1
Recombinant human anti-PD-L1 monoclonal antibody(Guilin Sanjin Pharmaceutical Co. Ltd.)
MSB-2311
HLX-37
Recombinant humanized anti-PD-L1 monoclonal antibody/human TGF-β fusion protein injection(Lepu Biopharma)
Recombinant anti-PD-L1 human monoclonal antibody(Jiangsu Huaiyu Pharmaceutical Co Ltd)
FAZ-053
LQ-004
JS-003
LQ-002
Carrizumab
Recombinant Anti-LAG-3 humanised Monoclonal Antibody (Shanghai Fosun Pharmaceutical)
GB7004
GB-7001
KY-1043
EGFR-targeting Monoclonal Antibodies (YUMAB)
Epidermal growth factor receptor tumour activated T-cell engager therapy (Janux Therapeutics/Merck & Co)
AWAKE LM TT
STW204
IMC-004
CX-188
LVGN5287
Recombinant human anti-PD-1 monoclonal antibody(CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co. Ltd.)
Programmed cell death 1 antibody(Sun Yat-Sen University)
BI-754091
Prolgolimab
SHR-1901
Budigalimab
Recombinant anti-PD-1 human antibody
GNR-051
Zeluvalimab
AK-107
IMGS-001
Sasanlimab
Sym-021
LQ-008
REMD-288
LQ-005
9MW1111
Recombinant humanized anti-PD-1 monoclonal antibody(Anhui Anke Biotechnology (Group) Co. Ltd.)
LVGN8325
BOXR-1030
ALG-070005
MK-3475A
OnCARlytics (Imugene)
MR1-targeted T-cell receptor cell therapies(Enara Bio)
CCX-4503
Recombinant humanized anti-PD-1 monoclonal antibody(Shanxi Weiqidaguangming Pharmaceutical Co Ltd)
TY-101
Serplulimab/HLX07
Anti-CD19 CAR-T cells therapy(Tianjin Mycure Medical Technology Co. Ltd)
IGV-001
Personalized clonal neoantigen-reactive T cells(Achilles Therapeutics)
OR-2805
SD-101(Dynavax Technologies Corp.)
EVX-02
Universal CARmesothelin-targeted T-cell therapy (Cellectis)
RNA-Meso-CIR-T
iCasp9M28z
KJ-C2113
BT-7401
PE-0116
ABP-1130
MT-301
MT-302
Codrituzumab
M-267
NKG 2A targeting therapy(Servier)
Shidaoping Powders
Interferon alpha-2b/interferon gamma(Center For Genetic Engineering And Biotechnology)
sulanemadlin
baloramotide
BTK/PI3K delta inhibitors (Curadev Pharma Pvt Ltd)
B03
PEP-06
NW-7-251
KP-0696S
KP-0936S
GT-19506
TQB-3820
SIAIS164018
SIAIS117
SIAIS091
YM281
ZB-S-29
EZH2-targetedPROTACs(Sichuan University)
YM181
SIAIS056
SIAIS001
HPB-001
BTK inhibitors(Fudan university/Shanghai Institute of Pharmaceutical Industry/China State Institute of Pharmaceutical Industry)
CLR-1700
BTK inhibitors (NTRC)
BTK inhibitors (Shenogen Pharma Group)
BTK inhibitors (Fujian Haixi Pharmaceuticals)
BTK inhibitors(Angel pharmaceuticals)
Everolimus/DTRMWXHS-12/Pomalidomide
Everolimus/DTRMWXHS-12
BTK modulators(X Rx, Inc.)
BTK inhibitor(Hainan Haiyao Co. Ltd.)
MT-106(Medytox)
ABP-1119
BTK inhibitor (Guangzhou BeBetter Medicine Technology)
SRX-3262
ML-319
YZJ-3058
GB-5121
Recombinant humanized monoclonal antibody MIL95(Beijing Mabworks Biotech Co. Ltd.)
IBI-397
SHR-1603
F527
Recombinant humanized anti-CD47 antibody(Lepu Biopharma)
IMC-002
Cannabidivarin/Cannabigerolic acid
AUTO-2
DF8000
DF8100
DF-4001
DF5008
DF4100
DF2200
DF-3001
DF-2001
p21 Activated Kinase Program(Turning Point Therapeutics, Inc.)
FLT3-Fc Fusion protein
Cancer vaccines(Iaso Therapeutics)
Colorectal cancer therapeutics(Servier)
ATRC-101
STC-15
ABBV-514
JTX-1811
INCB-106385
INCA-00186
INCB123667
INCB-099318
INCB-099280
Ieramilimab
Encelimab
BCM323
Tumour infiltrating lymphocytes therapy(RootPath)
T cell therapies(RootPath)
UCART-19
DC05F01
99mTc-3PRGD2
Tolerogenic Fibroblasts(FibroBiologics)
Dendritic cells vaccine(H. Lee Moffitt Cancer Center and Research Institute)
MAGE-A3(Memorial Sloan Kettering Cancer Center)
Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE(Thomas Jefferson University)
iCaspase9-transduced T cells(Baylor College of Medicine)
4SCAR-CD22(Shenzhen Geno-Immune Medical Institute)
Autologous Stem Cell(University of Miami)
Adoptive mononuclear cells therapy(Capital Medical University)
Ad-E6E7(Turnstone Biologics)
4SCAR20(Shenzhen Geno-Immune Medical Institute)
γδ T Cell(Beijing Doing Biomedical)
Allogeneic Granulocyte(Shanghai East Hospital)
DUOC-01
4SCAR-276(Sun Yat-sen University)
ChAd3-hliNSmut(GlaxoSmithKline)
Anti-GPC3 CAR-T cell therapy(NCI)
GSK adoptive cell therapy(GlaxoSmithKline)
NK Cell(Y-mAbs Therapeutics)
Neoantigen Peptide Vaccine(NCI)
Autologous lymphocytes(NCI)
hCE1m6-NSCs(NCI)
E7 TCR cells(NCI)
Anti-FLT3 CAR-T cell(PersonGen BioTherapeutics (Suzhou))
Tandem CAR19/20 engineered T cells(Chinese PLA General Hospital)
pp65-flLAMP DC(Immunomic Therapeutics)
multiTAA specific T cells(Baylor College of Medicine)
CD1c (BDCA-1)+/CD141 (BDCA-3)+ myDC(Universitair Ziekenhuis Brussel)
DKK1 loaded dendritic cell vaccine(Case Comprehensive Cancer Center)
RPTR-147(Merck Sharp & Dohme Corp.)
Murine CART19(University of Pennsylvania)
WT1-Sensitized Allogeneic T-Lymphocytes(Atara Biotherapeutics)
GM-CSF vaccine(Aduro Biotech)
Dendritic cells vaccine(Merck Sharp & Dohme Corp.)
Allogeneic lymphocytes(Sidney Kimmel Cancer Center at Thomas Jefferson University)
TVS-CTL Vaccine(University of Kansas Medical Center)
P140K-MGMT(NCI)
Allogeneic T cell therapy(Smart Immune SAS)
RNA-lipid Particle Vaccine(University of Florida)
GAd-PEV(Nouscom)
gp100:280-288 (288V) peptide vaccine(Bristol-Myers Squibb)
Tumor lysate-pulsed DC vaccination(Jonsson Comprehensive Cancer Center)
Anti-CD30 CAR T-cells(Josep Carreras Leukaemia Research Institute)
Irradiated Allogeneic Cells(NCI)
NSC-709401
Activated PTCy-MILs(NIH)
Adoptive cell therapy(Chinese PLA General Hospital)
P10s-PADRE/ MONTANIDE ISA 51 VG(University of Arkansas)
SCRI-huCAR19v1
TTRNA-DC vaccine(University of Florida)
PalloV-CC(PalloV)
B7H3 CAR T Cell(Seattle Children's Hospital)
GVAX(Dana-Farber Cancer Institute)
TetMYB Vaccine(Peter MacCallum Cancer Centre)
Autologous bone marrow derived MSCs therapy(Stem Med Pte)
TALEN-T512
SCRI-huCAR19v2
Dendritic Cell/AML Fusion Cell Vaccine(NCI)
haploid allogeneic NK cell(Shanghai iCELL Biotechnology)
WT1-Sensitized Allogeneic T-Lymphocytes(NCI)
WT1 mRNA-electroporated Langerhans cells(Memorial Sloan Kettering Cancer Center)
Neoantigen Peptide Vaccine(Instituto de Medicina Regenerativa)
Viral specific VST(Children's Hospital Medical Center, Cincinnati)
Neoantigen Peptide Vaccine(Fred Hutchinson Cancer Research Center)
Allogeneic memory T cell therapy(NCI)
Tumor Associated Antigen Specific T Cells(Children's National Research Institute)
Tumor antigen-specific IgT cells(Shenzhen Geno-Immune Medical Institute)
Microbial ecosystem therapeutics(NuBiyota)
Peripheral blood stem cells(NCI)
Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)(Istari Oncology)
Anti-CD19 CAR-T cell therapy(Affiliated Hospital to Academy of Military Medical Sciences)
CVD908ssb-TXSVN(Baylor College of Medicine)
pp65-shLAMP DC(Immunomic Therapeutics)
Adoptive cell therapy(Shanghai Biomed-union Biotechnology)
Lentivirus Vector rHIV7-shI-TAR-CCR5RZ-transduced HSCs(City of Hope Medical Center)
pNGVL3-hICD vaccine(NCI)
MVA-hliNSmut(GlaxoSmithKline)
DNR.NPC-specific T cells(Baylor College of Medicine)
Sleeping Beauty Transposed PBL(NCI)
Dendritic cells vaccine(Oslo University Hospital)
Ad-hCMV-Ad-hCMV-TKTK(University of Michigan Rogel Cancer Center)
Ad-hCMV-Flt3L(University of Michigan Rogel Cancer Center)
DC vaccines targeting HPV 16/18 E6/ E7 protein(Shenzhen People's Hospital)
Bcl-Xl_42-CAF09b vaccine(Herlev Hospital)
MesoPher(Amphera BV)
CT7
CAR.B7-H3(NIH)
Allogeneic CTL therapy(NCI)
HLA-A2 Restricted Tumor Antigen Peptides(NCI)
DNA-PEI polyplex(Belarusian Research Center for Pediatric Oncology, Hematology and Immunology)
Unpulsed DCs(Celldex Therapeutics)
MIDRIX-CTRL DCs(University Ghent)
mbIL21-expanded Haploidentical NK Cells(NCI)
Natural killer cell therapy(NCI)
Mesenchymal stem cells(NCI)
MT-201-GBM monocyte vaccine(NCI)
Dendritic cells vaccine(Karolinska University Hospital)
MP-0310
Pyronalidine tetraphosphate
Ortataxel
GH-57
GH-58
CBT-1
FA-S2-POMA
GH-31
Derazantinib
BDB-030
GH-51
MS170
PGV-001
CBP-312
DLBS-3233
COF-004
XTX-202
MS4078
GH-23
GH-52
Cancer vaccine-MUC 1
Tc-99m-annexin V-128
GH-53
ARB-101
OP-724
ARB-301
COF-002
MS-140
GH-56
BDB-018
Cancer immunotherapy target 'alpha' (Recursion Pharmaceuticals)
GT-002 (Glycotope)
hI-con1
Gastrointestinal cancer therapeutics (Recursion Pharmaceuticals)
AML-4
AML-3
Ovapuldencel-T(Caladrius Biosciences, Inc.)
CRX-100
ALKBH5-target therapeutics(RPXDS)
KDM5-target therapeutics(RPXDS)
ASN001(Shanghai Auson)
JAB-6343
JAB-2000
Chlorin-e6
Uzansertib
Ranpirnase
KJ-C2112
MG-1124
STI-5171
SC276
JAB-23000
PYX-106
DW-166HC
RCC-33
JS-104
SY-4835
BN104
FOG-001
Telratolimod
瘤内注射mRNA药物（斯微生物）
重组人促甲状腺素 (苏州智核生物医药)
波齐替尼
益气温阳解毒方
融合双质粒人乳头瘤病毒治疗性疫苗
艾姆地芬
安美木单抗 (中国人民解放军军事科学院军事医学研究院)
重组人源化抗TIGIT单克隆抗体(上海君实生物)
汉防己甲素
靶向CD19基因工程化自体T细胞(上海优卡迪)
可利霉素
大麻素
卡姆果提取物
GPCR拮抗剂(唯久生物)
华卟啉钠
甲磺酸氟马替尼
扶正解毒化瘀方
硫酸羟氯喹/西罗莫司
KRAS G12D抑制剂（上海艾力斯）
EGFR C797S抑制剂（上海艾力斯）
SOS1抑制剂（上海艾力斯）
内皮抑肽
RET抑制剂（艾力斯）
KRAS G12C抑制剂（上海艾力斯）
血管生成抑肽
德恩鲁胺
莫莫替尼
重组抗PD-1全人源单克隆抗体(上海昀怡健康科技发展有限公司)
抗CD19/CD20嵌合抗原受体自体T细胞(上海赛比曼生物科技)
SK08活菌散
安替安吉肽
汉黄芩素
盐酸哌罗替尼
二甲苯磺酸萘普替尼
盐酸西莫替尼
甲磺酸瑞泽替尼
西地尼布
苯胺洛芬
海博非明
盐酸阿糖胞苷缬氨酸酯
马来酸赛罗替尼
地塞米松玻璃体内植入(Aerie Pharmaceuticals, Inc.)
奥莫替尼
奥卡替尼
甲磺酸马赛替尼
重组人源化CTLA-4单域抗体Fc融合蛋白
二溴卫矛醇
苯磺酸克莱拉尼
艾诺赛特
盐酸卡呋色替
人参皂苷C-K
洛普替尼
托西酸伊菲替尼
康莫他赛
基于聚硅氧烷Gd-螯合物的纳米颗粒
抗人CD19 T细胞(恒润达生)
盐酸莎巴比星
菠萝蛋白酶(Mucpharm)
麦他替尼氨丁三醇
喜诺替康
对甲苯磺酰胺
尼莫唑
康普瑞丁磷酸二钠
盐酸米帕林
西维来司钠
多功能凋亡受体激动剂 (成都地奥九泓制药厂)
阿帕拉格鲁肽
盐酸领克尼斯
HMPL-453酒石酸盐
盐酸博昔替尼
去氧鬼臼毒素
马来酸英利替尼
普维替尼
吉马替康
克耐替尼
福大赛因
康尼替尼
赛博利塞
托拉利单抗(Opsona Therapeutics Ltd.)
姜黄素
海姆泊芬
盐酸胍立莫司
盐酸诺拉曲塞
靶向磷脂酰肌醇蛋白多糖-3嵌合抗原受体修饰的自体T细胞
马来酸苏特替尼
甲磺酸奥瑞替尼
重组EGF-CRM197肿瘤治疗性疫苗(上海惠盾生物)
重组抗HER2人源化HuA21单克隆抗体(合肥瀚科迈博生物技术有限公司)
醋酸地加瑞克
尤莱利单抗
抗原致敏的人树突状细胞(上海海欣生物)
自体天然肿瘤浸润淋巴细胞(上海君赛生物科技有限公司)
重组人源化抗CTLA-4单克隆抗体 (上海君实生物)
抗CD20 CART转导的T细胞 (中国人民解放军总医院)
靶向新生抗原自体免疫T细胞
MICB-vax疫苗
XYF19新型CAR-T细胞
治疗用人乳头瘤病毒16型重组腺病毒载体疫苗(浙江普康生物)
重组三价人乳头瘤病毒(16/18/58型)疫苗(大肠杆菌)(北京康乐卫士生物)
重组四价人乳头瘤病毒(16/18/52/58型)病毒样颗粒疫苗(毕赤酵母)(上海生物制品研究所)
重组腺病毒-胸苷激酶基因制剂
重组天冬酰胺酶
CGT-1403
A503
TC-L300S
Intratumoral Immuno-Oncology Therapeutics (Stemirna Therapeutics)
Gedatolisib
CPT01
Recombinant human thyroid stimulating hormone(Suzhou SmartNuclide Biopharmaceutical Co. Ltd.)
Bright
CPT04
CPT02
Mavorixafor
LAE-102
CPT03
SNA011
Apollo
SNA004
SNA-011-177Lu
SNA-017-177Lu
SNA017
APS03118
OBX-115
Camonsertib
SNA018
H3B-6527
Bersiporocin dihydrochloride
H3B-8800
Poziotinib
VTH-140
CD19-CAR-DNT Cells(Zhejiang Ruijiamei Biotechnologies, Co. Ltd.)
Thymoquinone
Yiqi Wenyang Jiedu Prescription
Yangyin Fuzheng Jiedu Prescription
Wharton's Jelly Mesenchymal Stem Cell(PT. Prodia Stem Cell Indonesia)
Ofranergene obadenovec
AMV-002
MCPγV-LT vaccine(Immunomic Therapeutics)
MIL-97
Uprosertib
Bezuclastinib
RAP-103
Umitrelimorgene Autodencel
MDK-703
Milataxel
XY-B001
YL-15293
IMMH-010
TT-00434
H-1710
Neuroblastoma vaccine(Memorial Sloan-Kettering Cancer Center)
99mTc-HPArk2
Membrane bound ligand T-SIGn virus
177Lu-PSMA-I&T
Aviscumine
LMP2-Specific IL12-secreting TCR-T Cell therapy (TCRCure Biotech)
Recombinant human anti-EGFR mAb(Academy of Military Medical Sciences)
Varlitinib Ditosylate
C-CAR031
ABOD2011
AXT1003
TransJoin
AXT-3001
TORL-2-307-MAB
WP1 cancer vaccine(BioNTech SE)
PRJ1-3024
Fluorescein-Specific CAR T Cells(Umoja Biopharma, Inc.)
Labvax (LabyRx Immunologic Therapeutics)
MK-1484
ZX-5000
6-thio-2'-deoxyguanosine
PEG [SN22]4
EO-4010
AXT1005
INV-25
AXT-3003
QHRD-110
Anti-CD7 CAR-T- cell therapy (PersonGen Biomedicine)
JS-006
JS-012
NBL-015
IMP-7068
NB-005
LVGN-7409
PM-1015
TQB-3909
TQB-3811
SH-3765
TQB-3824
SPH-5030
Lithium gamolenate
RBS-2418
LTA-001
Tetrandrine
INV501
NK cell therapeutics(EdiGene/Neukio Biotherapeutics)
SAR444200
ES-3000 (Escend Pharmaceuticals)
RGT-419B
ES-4000
AB-245
E-7046
BAT-6005
ET-0038
HRS-2300
HNC664
ICP-189
HTPEP-001
HTMC-0370
HMPL-760
HH-3806
TQB3915
CBP-1039
CUSP01
Anti-PD1 BCMA chimeric antigen receptor T cell therapy(BRL medicine)
CAP-6
HFB-3010
iPSC-derived CAR T-cell therapy(Kyoto University)
RAG-02
RAG-01
EO-2463
BC008
JNJ-80038114
TGRX-326
TGRX-072
Bifunctional HER2-Sialidase(Palleon Pharmaceuticals)
NW-8-153
Autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells(Shanghai Unicar)
A-1211212
CG016
SAR-156497
SYC-435
AEZS-131
PFI-90
PMI-21
SH-7129
ITE (AhR Pharmaceuticals)
Dimesna
CPL-043
BMD-20
ANP-005
the-104
ALM-756
DRGT-82
BCY-3814
the-105
UBP-1212
OICR-10268
ABK-356
CG-202
BPM-18708
TN-1161
DN-1609
MIR-002
GPB-730
MA9-060
L-80
APC-003
SHP-1705
ADT-061
SPH-6162
EBT-001
HERA-CD137L
7A5 (Eli Lilly & Co.)
APL-1401
SH-7133
SR-38832
DXI (NKD Pharma Co. Ltd.)
Lys-01
MIR-020
LEAF-1701
TL-398
SI-12
AVA-026
CCL19-Vault
anti-miR-214
APC-004
anlutini
LS-007
HE-003
KTX-105
MS-351
INA-01
RJS-DIAG1
E-260
hu91
FCBL (Changsha Huozi Biotechnology Co. Ltd.)
MP-2018
SRI-40000
ERG-344
NCI-006
ADTL-EI-1712
KU-004
EVT-601
TRX-606
OTL-228
P-916
ANK-101
NCGC-1481
MaaT-03X
OMTX-001
NTC-001
GBO-006
HH-102
NiceR
VDA-1270
NUV-1156
MDNA-56
FSX-7742
PE-0121
PB-10
EUD-GK-91
TAM-03
HH-201
TPH-104
SKLB-677
LND-700110
SJP-1601
M-4205
WXSH-0011
MTX-211
JS-403
VFV (Vanderbilt University)
MesoTarg
BC-010
SP-141
PolyPEPI-916
STX-3329
SAH-EJ1
OPX-212
GR-009
NEO-214
C-150
xl-150
UniPR-1331
the-103
B10G5
TNB-404
ASR-458
BAY-320
DU-325
RJS-05X
DRB-18
Equin
GRC-5XXX
FC101
LBS-002
B-12
VRN-03
INV-71
S-61904
MelanoVax
ITF-3756
PPMX-T002
KTX-154
SKLB-287
IDP-410
RC-04
FOR-7191
SS-34
IMM-02
O-10554
JBI-300
TTT-3002
PCNT-13
31.1C
NEXI-003
STIM-41BBL
OTS-193320
ZKN-013
EUD-GK-001
TLP-019
MRK-560
MIA-313
MI-223
NOV-1502
IL17-Vault
IMM-2019611
DRGT-81
TH-9619
LBL-001
H5A10
PFI-103
NGT-008
WPD-103
SGL-10060
AN9015
P-975
ESA-1121
AZ-1495
APH-0804
JRP-890
DL-5055
IMA-403
CPI-381
A-395
JAB-3068
BO-264
ST-201
ARD-MM1
SJP-1901
TL-241
SAR-439115
SYC-836
AS-10
APC-002
BN-210
2P-Im
VNI-101
ONCOS-X02
AG-101
STX-301
TMAB (PharmaPraxis)
UMI-77
IA-116
HM-27
TSCP-2
CTA-001
BS-104
AECase
SIMR-1281
C10.36
KIN-4064
TNF-07
KIN-4104
CG-223
C-019199
BGI-0002262
B-007
KIN-2160
CCT-368408
KM-101
MegaOX40L (Multimeric Biotherapeutics, Inc.)
ADT-007
GH-21
KT-220
SU-093
Bcl-848
ZBH-01
MDNA-132
C008-D
TDI-003410
GL-251
FGTI-2734
UC-514321
GEM-144
ATHX-04
P-1309
IMP-03124
GH-501
CV-08-01
CVT-100077
iDCtWT1 (King's College London)
MDNA-57
SHF-1036
PH-427
MP-2019
XC-201
OTX-2002
XZ.700
AZ-67
ITB-02
ICT-12035
JG-98
AST-56100
SH-7113
the-106
J-21475
SST-215
CT-7439
BSCHL-2046
KHS-101
LCC-03
CS-3158
OR-682
ANAVEX-1067
MTB-8265
NPS-1034
LS-177
BMS-159
ICT-2588
LB-200
LJ-2618
CWIV-053
AST-6828
OSU-13
KBP-7018
ODS-2005294
RJS-DIAG2
PLG-201
BNL-101
ARN-22089
rNDV/F3a (University of Guelph)
AWT-P1790
AZ-1422
YTR-107
LB-P2D
DS-9606a
NK cell therapeutics (Neukio Biotherapeutics)
JNTX-104
Carrimycin
HF1K16
Peptide-based radiopharmaceuticals (48Hour Discovery)
GH-36
FEP-633
PGV002 mRNA vaccine
Tie2 expressing monocytes immuno gene therapies (Genenta Science)
AST-1601
BBI-355
GTX-0196
DEVA-OV3
GDX-056
CN1
mRNA based iPS cellderived macrophages (Factor Bioscience)
TAS-3351
USP-1
LAG3-targeted IL15 Fc fusion proteins (Xencor)
GAIA-122
GH-39-006
Cannabinoid extract (Cannabotech)
SNV-103
SB-24011
GH39-017
S-216096
UP-284
MW005
PROTAC
MTX-103
TAR-003
EI-201
mut-1N-IL-15/38B2
S-95035
BDR-165
Solid tumor mRNA vaccine (Haichang Biotechnology)
GENA-111-ADC
BDR-167
Iodine-131 CAM FAP
BDR-166
WII-2105
kt-3283
AMT-754
REC-65029
RM-029
GSPT1 degrader (Degron)
Prostate cancer vaccine (pHion Therapeutics)
mRNA based neo-antigens immunotherapy (CureVac)
RNA-based tumor associated antigens immunotherapy (CureVac)
ZX-8177
AMB-018
WEE1 protein kinase degrader (Degron)
ADPc-389
JNC-1043
Fc3TSR
RNA tumor vaccine (Huawe Medicine)
Ubiquitin specific protease 7 targeting therapeutic (Molecure)
MT-8421
GB-2102
RVL-002
radiopharmaceuticals (Ratio Therapeutics)
TAR-001
DYP-688
DEVA-OV4
HCW-9213
CART-38 Cellls(University of Pennsylvania)
Cancer1 Alphyn Biologics
Actinium-225 CAM FAP
CBM-F1
VRTX-126
MTX-101
TAR-002
Autologous T-cell therapy (Kairos)
GENA-107
CAM-161519
212Pb peptide receptor radionuclide therapy (Orano Med)
3D011-08
PF-07265807
ANT-045
Simurosertib
SBT-6290
Anti PD L1 immune stimulating antibody conjugate (Bolt Biotherapeutics)
ANT-043
CX-072
NX-1607
GT316
Cannabinoids
177-lutetium PNT 2001
Imlunestrant
CGT-1881
GT-307
BT-1718
HBI 0201-ESO TCRT
Mosedipimod
HH-009
IBI395
RGX-104
Myrciaria Dubia Extract
TP-5809
LB1908
BT-7480
BKX-001
MSB-11431
Ipilimumab biosimilar(Eden Biologics)
Trastuzumab Biosimilar(Outlook Therapeutics/Parilis/Zhejiang Huahai)
AVT-33
FPT-155
AT-004 (Adept Biopharma)
JNJ-8902
MTB-22252
CS-1010
SP23
LJ-4827
TX-542
TNG-260
ONK-006
IACS-8803
Yinkang008
ASP-3082
C-176
IBRX-042
CAR-T(Yinkang Biopharma, Inc)
CF501/RBD-Fc
Yinkang001
Small molecule G protein coupled receptor modulators (Domain Therapeutics)
CS-1018
CF3-002
ONK-002
ONM-300
HCI-1046
GM-10395
ACTM-838
H-151
ONK-003
SR-717
ERX-315
C-178
CS-1020
AM-1882
MSA-1
AM-5308
GM-90581
Caflanone (Flavocure Biotech)
SR-8314
ONK-008
IACS-8779
diABZI-2
BRG-399
TCR(Yinkang Biopharma, Inc)
ONK-005
CYG-N-2278
YDC-101
BLX-3030
ONK-004
GPCR antagonist(Weijiu Biological)
B cell therapies (Be Biopharma)
BDTX-4933
ONK-001
CART-NHL-1
PC7A
HFDOX
MK-1088
ONK-007
SN-011
EMU-116
RGBP-248
MSA-2
TNG-462
Affinityenhanced Tcell receptors (Adaptimmune)
JMKX-003162
CHS-7304
ERX-342
RGX-202
Birch bark extract
RVU-27065
TAA5 CAR T
MVA Brachyury TRICOM vaccine (Bavarian Nordic)
ALG-031048
SNX-281
HG-381
MK-2118
GSK-532
IMGS-501
OX-401
SynOV 2
Vigil Breast(Gradalis)
BNT-114
ODI-2001
Oncogenic Driver Program: Mutant P53 (Affini-T Therapeutics, Inc.)
GP 01CR11
BIIB-022
Oral T-cell immunotherapies (NEC Corporation/VAXIMM)
VIP-236
HBW-1020
DSP-5336
Actinium-225 CAM FAP(Precirix)
GAIA-102
212Pb-PRRT
IPS-06040
HS248
ABSK-011
IPS-06010
212Pb-PLE
Anti-PDL1/IL10 fusion protein (Pilatus Biosciences)
IPS-06060 (MG degrader)
BM201
212Pb-AR-RMX
Sinoporphyrin Sodium
P-11 (InnoPharmaScreen)
Y08
BPI-16350
YPD-30
CD19 HLE BiTE
Flumatinib Mesylate
Pamufetinib
AVX-701
AZD9574
Autologous Epstein-Barr virus-specific T-cell therapy(Atara Biotherapeutics, Inc.)
KD-045
TT-373
Bi-shRNAfurin and GMCSF augmented autologous tumor cell immunotherapy(Gradalis, Inc.)
EB-160
TQB2930
BMS-986406
Gallium-68 NOTA hGZP
DAN-222
Debio-4126
BMS-986408
KJ-015
TGRX-1942
KJ-036
JL19001
JL-18004
KAN-0441571C
Autologous Activated T Lymphocytes(Lukas Biomedical Inc.)
DZD-1516
CDMO-002
Fuzheng Jiedu Huayu Principle
JL-18008
Revumenib
CDMO-001
177Lu-EB-FAPI
CT101a
TGRX-814
S-288310/S-488310
G-207
Gimsilumab
Marizomib
PHI-201
KPG-419
CG-416
AIT-102
Hydroxychloroquine sulfate/Sirolimus
Limertinib
SLSP-03
CONV 01-alpha + PSMA I&T
SG233
X4P-002
PM-3023
PM-3006
UM01
Pirarubicin Hydrochloride
TAA6-CAR-T
161Tb-DOTA-LM3
JWATM204
ASP3082
JBPOS0755
ICP-490
Solid tumors therapy (Kintai Therapeutics)
HGXJT Decoction
RP903
ADD428012
GR-011
MYC Project(Omega Therapeutics)
ADD532005
[18F]FAPI-74
Colorectal cancer therapy (Kintai)
177Lu-EB-LM3
Small Cell Lung Cancer(Omega Therapeutics)
GP-01CR21
OATD-02
Bevacizumab biosimilar (AskGene Pharma)
LAS-20
苏公网安备 32059002004080号
